<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
      <journal-id journal-id-type="publisher-id">ijms</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Molecular Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1422-0067</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">32054031</article-id>
      <article-id pub-id-type="pmc">7072809</article-id>
      <article-id pub-id-type="doi">10.3390/ijms21041193</article-id>
      <article-id pub-id-type="publisher-id">ijms-21-01193</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>MiRNAs and LncRNAs: Dual Roles in TGF-&#x3B2; Signaling-Regulated Metastasis in Lung Cancer</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lai</surname>
            <given-names>Xing-Ning</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn1-ijms-21-01193">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2014-7996</contrib-id>
          <name>
            <surname>Li</surname>
            <given-names>Jun</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn1-ijms-21-01193">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4870-4408</contrib-id>
          <name>
            <surname>Tang</surname>
            <given-names>Li-Bo</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Wen-Tong</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Lei</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3769-2496</contrib-id>
          <name>
            <surname>Xiong</surname>
            <given-names>Li-Xia</given-names>
          </name>
          <xref rid="c1-ijms-21-01193" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-ijms-21-01193">Department of Pathophysiology, Jiangxi Province Key Laboratory of Tumor Pathogenesis and Molecular Pathology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China; <email>laixingning99@outlook.com</email> (X.-N.L.); <email>lj012729@163.com</email> (J.L.); <email>lb525912836@163.com</email> (L.-B.T.); <email>c0813408@163.com</email> (W.-T.C.); <email>zhangleihen6@163.com</email> (L.Z.)</aff>
      <author-notes>
        <corresp id="c1-ijms-21-01193"><label>*</label>Correspondence: <email>xionglixia@ncu.edu.cn</email>; Tel.: +86-791-8636-0556</corresp>
        <fn id="fn1-ijms-21-01193">
          <label>&#x2020;</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>2</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>2</month>
        <year>2020</year>
      </pub-date>
      <volume>21</volume>
      <issue>4</issue>
      <elocation-id>1193</elocation-id>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>12</month>
          <year>2019</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>2</month>
          <year>2020</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2020 by the authors.</copyright-statement>
        <copyright-year>2020</copyright-year>
        <license license-type="open-access">
          <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Lung cancer is one of the most malignant cancers around the world, with high morbidity and mortality. Metastasis is the leading cause of lung cancer deaths and treatment failure. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs), two groups of small non-coding RNAs (nc-RNAs), are confirmed to be lung cancer oncogenes or suppressors. Transforming growth factor-&#x3B2; (TGF-&#x3B2;) critically regulates lung cancer metastasis. In this review, we summarize the dual roles of miRNAs and lncRNAs in TGF-&#x3B2; signaling-regulated lung cancer epithelial-mesenchymal transition (EMT), invasion, migration, stemness, and metastasis. In addition, lncRNAs, competing endogenous RNAs (ceRNAs), and circular RNAs (circRNAs) can act as miRNA sponges to suppress miRNAs, thereby mediating TGF-&#x3B2; signaling-regulated lung cancer invasion, migration, and metastasis. Through this review, we hope to cast light on the regulatory mechanisms of miRNAs and lncRNAs in TGF-&#x3B2; signaling-regulated lung cancer metastasis and provide new insights for lung cancer treatment.</p>
      </abstract>
      <kwd-group>
        <kwd>miRNAs</kwd>
        <kwd>lncRNAs</kwd>
        <kwd>TGF-&#x3B2; signaling</kwd>
        <kwd>miRNA sponges</kwd>
        <kwd>lung cancer</kwd>
        <kwd>metastasis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-ijms-21-01193">
      <title>1. Introduction</title>
      <p>Lung cancer is the most common cancer based on current diagnoses and the leading cause of cancer-related deaths globally [<xref rid="B1-ijms-21-01193" ref-type="bibr">1</xref>]. According to the data from the GLOBOCAN database, it is estimated that 2.09 million new cases (11.6% of total cancer cases) and a mortality of 1.76 million (18.4% of total cancer-related deaths) of lung cancer were found worldwide in 2018 [<xref rid="B2-ijms-21-01193" ref-type="bibr">2</xref>]. Lung cancer can be divided into small cell lung cancer (SCLC) (15%) and non-small cell lung cancer (NSCLC) (85%). NSCLC contains three major subtypes: lung adenocarcinoma (40%), lung squamous cell carcinoma (25&#x2013;30%), and large cell carcinoma (10&#x2013;15%) [<xref rid="B3-ijms-21-01193" ref-type="bibr">3</xref>,<xref rid="B4-ijms-21-01193" ref-type="bibr">4</xref>]. Lung cancer development is mostly correlated with genetic mutations and environmental interactions, such as cigarette smoking, radiation exposure, and toxic substances [<xref rid="B5-ijms-21-01193" ref-type="bibr">5</xref>]. Presently, metastasis and recurrence are the main causes of death for lung cancer patients [<xref rid="B6-ijms-21-01193" ref-type="bibr">6</xref>]. Statistics show that approximately two-thirds of patients have metastatic lesions when they are first diagnosed with lung cancer [<xref rid="B7-ijms-21-01193" ref-type="bibr">7</xref>]. Although there are many therapies (surgical resection, chemotherapy, radiotherapy, etc.) to treat lung cancer, the overall five-year survival rate of lung cancer patients is still as low as 17.7% [<xref rid="B8-ijms-21-01193" ref-type="bibr">8</xref>], and the overall five-year survival rate of patients with distant organ metastasis is 4.5% [<xref rid="B9-ijms-21-01193" ref-type="bibr">9</xref>]. Therefore, it is necessary to explore the metastatic mechanisms of lung cancer, as finding new strategies to diagnose and treat lung cancer is of great significance.</p>
      <p>MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are small non-coding RNAs (nc-RNAs) without the potential to encode proteins [<xref rid="B10-ijms-21-01193" ref-type="bibr">10</xref>]. Nevertheless, these RNAs can regulate gene transcription and translation by interacting with the 3&#x2032; untranslated region (3&#x2032;UTR) of messenger RNA (mRNA) [<xref rid="B11-ijms-21-01193" ref-type="bibr">11</xref>,<xref rid="B12-ijms-21-01193" ref-type="bibr">12</xref>]. Functionally, they can regulate various cellular processes, such as cell proliferation, differentiation, and apoptosis [<xref rid="B13-ijms-21-01193" ref-type="bibr">13</xref>,<xref rid="B14-ijms-21-01193" ref-type="bibr">14</xref>]. Further, these two RNAs have been found to play anti-carcinogenic or oncogenic roles in lung cancer progression, and their aberrant expressions can give rise to the malignant developments of lung cancer, such as migration, invasion, and metastasis [<xref rid="B15-ijms-21-01193" ref-type="bibr">15</xref>]. Additionally, miRNAs and lncRNAs can also be used as biomarkers to predict the outcomes of lung cancer patients [<xref rid="B16-ijms-21-01193" ref-type="bibr">16</xref>]. Accumulating reports have found that both lncRNAs and miRNAs can regulate the transforming growth factor-&#x3B2; (TGF-&#x3B2;) signaling pathways, thus affecting lung tumor migration, invasion, and metastasis [<xref rid="B17-ijms-21-01193" ref-type="bibr">17</xref>,<xref rid="B18-ijms-21-01193" ref-type="bibr">18</xref>]. Some lncRNAs can modulate the TGF-&#x3B2;-induced epithelial-mesenchymal transition (EMT) by interacting with miRNAs [<xref rid="B19-ijms-21-01193" ref-type="bibr">19</xref>,<xref rid="B20-ijms-21-01193" ref-type="bibr">20</xref>]. TGF-&#x3B2;, a multifunctional cytokine, has three isoforms, TGF-&#x3B2;1, TGF-&#x3B2;2, and TGF-&#x3B2;3 [<xref rid="B21-ijms-21-01193" ref-type="bibr">21</xref>]. It can usually potentiate migration, invasion, and metastasis in lung cancer [<xref rid="B22-ijms-21-01193" ref-type="bibr">22</xref>].</p>
      <p>In this review, we summarize the positive and negative roles of lncRNAs and miRNAs in TGF-&#x3B2; signaling-regulated lung cancer metastasis, hoping to provide new insights for the design of more efficient therapies for lung cancer treatment in the future.</p>
    </sec>
    <sec id="sec2-ijms-21-01193">
      <title>2. Overview of miRNAs and lncRNAs</title>
      <sec id="sec2dot1-ijms-21-01193">
        <title>2.1. MiRNAs</title>
        <p>MiRNAs, 18~25 nucleotides in length, can bind to miRNA response elements (MREs) on the target mRNA 3&#x2032;UTR and silence target genes through mRNA degradation or by suppressing mRNA translation [<xref rid="B23-ijms-21-01193" ref-type="bibr">23</xref>]. Notably, each miRNA can target various mRNAs, thereby mediating several genes; each gene can also be regulated by multiple miRNAs [<xref rid="B24-ijms-21-01193" ref-type="bibr">24</xref>]. At present, miRNAs are attracting increasingly more attention due to the fact that their dysregulation plays a critical role in many human diseases, especially cancers [<xref rid="B25-ijms-21-01193" ref-type="bibr">25</xref>]. Abnormal miRNA expression is always associated with lung cancer progression [<xref rid="B26-ijms-21-01193" ref-type="bibr">26</xref>]. Furthermore, miRNAs can cause resistance to drugs and radio-chemotherapy in lung cancer patients, contributing to low therapeutic efficiency [<xref rid="B27-ijms-21-01193" ref-type="bibr">27</xref>]. They can also be predictors for lung cancer prognosis [<xref rid="B28-ijms-21-01193" ref-type="bibr">28</xref>].</p>
      </sec>
      <sec id="sec2dot2-ijms-21-01193">
        <title>2.2. LncRNAs</title>
        <p>LncRNAs are another class of nc-RNAs with more than 200 nucleotides in length. In the cell nucleus, lncRNAs can modify chromatin structures by interacting with polycomb repressive complex 2 (PRC2), enhance or reduce gene transcription by recruiting transcription factors, and regulate miRNA processing [<xref rid="B29-ijms-21-01193" ref-type="bibr">29</xref>]. In the cytoplasm, lncRNAs can mediate mRNA translation, increase or decrease mRNA stability, and act as miRNA sponges that can repress miRNAs [<xref rid="B29-ijms-21-01193" ref-type="bibr">29</xref>,<xref rid="B30-ijms-21-01193" ref-type="bibr">30</xref>]. LncRNAs can participate in the pathogenesis of various human diseases, particularly cancers [<xref rid="B31-ijms-21-01193" ref-type="bibr">31</xref>]. LncRNAs have similar carcinogenic and anti-carcinogenic capacities to miRNAs, affecting lung cancer proliferation, migration, invasion, and metastasis [<xref rid="B32-ijms-21-01193" ref-type="bibr">32</xref>]. Particularly, lncRNAs play a critical role in drug resistance. Targeting lncRNAs may help increase drug sensibility during lung cancer treatments [<xref rid="B33-ijms-21-01193" ref-type="bibr">33</xref>].</p>
      </sec>
    </sec>
    <sec id="sec3-ijms-21-01193">
      <title>3. TGF-&#x3B2; Signaling Is Involved in Lung Cancer Metastasis</title>
      <sec id="sec3dot1-ijms-21-01193">
        <title>3.1. TGF-&#x3B2; Signaling Regulates Cell Migration and Invasion</title>
        <p>TGF-&#x3B2; mediates the EMT process mostly via the Smad (<xref ref-type="fig" rid="ijms-21-01193-f001">Figure 1</xref>) pathways. In this model, activated TGF-&#x3B2; first binds to TGF-&#x3B2; receptor 2 (TGFBR2), which can recruit and then phosphorylate TGFBR1. Subsequently, phosphorylated TGFBR1 activates Smad2 and Smad3. Smad2/3 can bind to Smad4 and enter into the cell nucleus to regulate the expression of EMT-associated genes or factors [<xref rid="B34-ijms-21-01193" ref-type="bibr">34</xref>]. TGF-&#x3B2; can increase the expression of EMT-inducing transcription factors, such as Snail1, Slug (Snail2), and Zinc finger E-box-binding homeobox 1 and 2 (ZEB1/2) [<xref rid="B35-ijms-21-01193" ref-type="bibr">35</xref>]. These transcription factors can repress E-cadherin expression to induce EMT in lung cancer [<xref rid="B36-ijms-21-01193" ref-type="bibr">36</xref>]. TGF-&#x3B2; can also function through non-Smad (<xref ref-type="fig" rid="ijms-21-01193-f001">Figure 1</xref>) pathways to modulate lung cancer EMT, such as the nuclear factor-kappa B (NF-&#x3BA;B)/Snail [<xref rid="B37-ijms-21-01193" ref-type="bibr">37</xref>], Janus-activated kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) [<xref rid="B38-ijms-21-01193" ref-type="bibr">38</xref>], phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT), and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase 1/2 (ERK1/2) [<xref rid="B39-ijms-21-01193" ref-type="bibr">39</xref>] pathways.</p>
        <p>TGF-&#x3B2; can induce Snail, Slug, and ZEB2 expression to decrease E-cadherin, resulting in breaking adherens junctions [<xref rid="B40-ijms-21-01193" ref-type="bibr">40</xref>]. TGF-&#x3B2; can bind to TGFBR2 and then phosphorylate Par6 to recruit SMURF1. Then, SMURF1 can degrade RhoA to increase the dissolution of junctional complexes and thereby reduce cell&#x2013;cell adhesions [<xref rid="B41-ijms-21-01193" ref-type="bibr">41</xref>]. In contrast to cell&#x2013;cell adhesions, cell&#x2013;matrix adhesions are always enhanced in lung cancers (<xref ref-type="fig" rid="ijms-21-01193-f001">Figure 1</xref>). In A549 cells, TGF-&#x3B2;1 can activate the PI3K/AKT/NF-&#x3BA;B signaling pathway to increase &#x3B2;1 integrin expression, which may facilitate integrin-mediated cell migration [<xref rid="B42-ijms-21-01193" ref-type="bibr">42</xref>]. TGF-&#x3B2;/Smad3 signal can increase &#x3B1;5&#x3B2;1 integrin expression by down-regulating zyxin. Up-regulated &#x3B1;5&#x3B2;1 integrin can enhance A549 cell adhesion to the fibronectin, as well as increase migration [<xref rid="B43-ijms-21-01193" ref-type="bibr">43</xref>].</p>
        <p>Invadopodia can degrade the surrounding extracellular matrix (ECM) through matrix-degrading proteinases, such as membrane type 1 matrix metalloprotease (MT1-MMP), MMP2, MMP9, cathepsin B, and a disintegrin and metalloprotease 12 (ADAM12), thus propelling cell invasion [<xref rid="B44-ijms-21-01193" ref-type="bibr">44</xref>,<xref rid="B45-ijms-21-01193" ref-type="bibr">45</xref>]. In H157 cells, TGF-&#x3B2; can increase pFAK, Src, cortactin, and ERK in response to &#x3B2;3 integrin, eventually resulting in forming a mature invadopodia with proteolytic activity (<xref ref-type="fig" rid="ijms-21-01193-f001">Figure 1</xref>) [<xref rid="B46-ijms-21-01193" ref-type="bibr">46</xref>].</p>
      </sec>
      <sec id="sec3dot2-ijms-21-01193">
        <title>3.2. TGF-&#x3B2; Signaling Regulates Lung Cancer&#x2019;s Distant Metastasis</title>
        <p>Lung tumor cell intravasation is involved in migrating to and then passing through the vessel wall. Tumor cells not only secrete TGF-&#x3B2;1 but also bind to Notch ligands on endothelial cells (ECs) by using Notch receptors, thus facilitating their transmigration through the endothelial tight junctions [<xref rid="B47-ijms-21-01193" ref-type="bibr">47</xref>]. TGF-&#x3B2; can increase &#x3B2;3 integrin expression to enhance H157 cell adhesion to lymphatic endothelial cells (LECs), subsequently promoting cell transmigration across LEC monolayers [<xref rid="B48-ijms-21-01193" ref-type="bibr">48</xref>]. The consequences of successful intravasation are indicated by the appearance of circulating tumor cells (CTCs) in circulation.</p>
        <p>Lung CTCs can produce the immune suppressors interleukin-10 (IL-10) and TGF-&#x3B2;. Moreover, TGF-&#x3B2; can increase circulating CD4+CD25+ regulatory T cells (Tregs) via the cyclooxygenase-2 (Cox-2)/prostaglandin E2 (PGE2) signaling pathway. These Tregs can suppress the proliferation of CD4+ T cells, thus driving CTCs to escape from immune attacks (<xref ref-type="fig" rid="ijms-21-01193-f002">Figure 2</xref>) [<xref rid="B49-ijms-21-01193" ref-type="bibr">49</xref>]. In A549 cells, the TGF-&#x3B2;1/Smad2 signaling pathway can up-regulate programmed cell death ligand-1 (PD-L1) [<xref rid="B50-ijms-21-01193" ref-type="bibr">50</xref>]. PD-L1 can bind to programmed cell death protein-1 (PD-1), expressed on activated T cells and other immune cells, ultimately suppressing anti-tumor immunity in NSCLC [<xref rid="B51-ijms-21-01193" ref-type="bibr">51</xref>]. In H1355 and H1299 cells, TGF-&#x3B2; can induce miR-183 to down-regulate major histocompatibility complex class I chain-related A (MICA) and MICB expression, which can help H1355 and H1299 cells evade immune detection mediated by the circulating immune cells that express NKG2D (the transmembrane glycoproteins that can recognize MICA and MICB), thereby driving immune evasion (<xref ref-type="fig" rid="ijms-21-01193-f002">Figure 2</xref>) [<xref rid="B52-ijms-21-01193" ref-type="bibr">52</xref>].</p>
        <p>CTCs are usually arrested in narrow capillaries, where they can be trapped because of the size restriction and then extravasate [<xref rid="B53-ijms-21-01193" ref-type="bibr">53</xref>]. In A549 cells, the TGF-&#x3B2;/Smad3 signaling pathway can induce a DOCK4 expression to activate Rac1. Then, Rac1 activation can extend protrusions to promote the extravasation of A549 cells (<xref ref-type="fig" rid="ijms-21-01193-f002">Figure 2</xref>) into distant organ sites [<xref rid="B54-ijms-21-01193" ref-type="bibr">54</xref>]. Lung cancer cells are most likely to form metastases in the brain, bones, and lymphatic nodes [<xref rid="B55-ijms-21-01193" ref-type="bibr">55</xref>]. In H460 cells, TGF-&#x3B2; can increase the levels of TCF4, PRKD3, and SUSD5. The combination of these triple factors can enhance osteolytic lesions that can increase bone colonization [<xref rid="B56-ijms-21-01193" ref-type="bibr">56</xref>]. In A549 cells, TGF-&#x3B2;/Smad2/3 signaling is required for the combination of HDAC4, PITX1 and ROBO1. This combination can promote osteolytic lesions, thereby promoting bone colonization (<xref ref-type="fig" rid="ijms-21-01193-f002">Figure 2</xref>) of A549 cells [<xref rid="B57-ijms-21-01193" ref-type="bibr">57</xref>].</p>
      </sec>
    </sec>
    <sec id="sec4-ijms-21-01193">
      <title>4. Roles of miRNAs in TGF-&#x3B2; Signaling-Regulated Lung Cancer Metastasis</title>
      <sec id="sec4dot1-ijms-21-01193">
        <title>4.1. Positive Roles of miRNAs</title>
        <sec id="sec4dot1dot1-ijms-21-01193">
          <title>4.1.1. MiR-93</title>
          <p>MiR-93 is up-regulated in NSCLC tissues [<xref rid="B58-ijms-21-01193" ref-type="bibr">58</xref>]. The neural precursor cell expressed developmentally downregulated gene 4-like (NEDD4L) was predicted to be its target by miRDB and TargetScan. MiR-93 can bind to the mRNA 3&#x2032;UTR of the NEDD4L and then down-regulate its expression. Down-regulated NEDD4L can increase Smad2 phosphorylation to enhance TGF-&#x3B2; signal transduction, finally promoting TGF-&#x3B2;-induced EMT in A549 and H1650 cells [<xref rid="B59-ijms-21-01193" ref-type="bibr">59</xref>]. In addition, increased miR-93 can predict poor outcomes among NSCLC patients [<xref rid="B60-ijms-21-01193" ref-type="bibr">60</xref>].</p>
        </sec>
        <sec id="sec4dot1dot2-ijms-21-01193">
          <title>4.1.2. MiR-128-3p</title>
          <p>MiR-128-3p is highly expressed in NSCLC tissues compared to adjacent normal tissues. It can inhibit SMURF2 and the catalytic subunit of protein phosphatase 1 (cPP1) expressions by targeting their mRNA 3&#x2032;UTRs, eventually activating the TGF-&#x3B2; signaling pathways to promote EMT, metastasis, and chemoresistance. Further, high miR-128-3p expression can indicate poor NSCLC patient survival [<xref rid="B61-ijms-21-01193" ref-type="bibr">61</xref>].</p>
        </sec>
        <sec id="sec4dot1dot3-ijms-21-01193">
          <title>4.1.3. MiR-9</title>
          <p>MiR-9 is up-regulated in NSCLC cell lines and can be up-regulated by TGF-&#x3B2;1. MiR-9 can promote TGF-&#x3B2;-induced EMT by inhibiting E-cadherin in A549 cells [<xref rid="B62-ijms-21-01193" ref-type="bibr">62</xref>]. In addition, miR-9 can also repress SRY-Box 7 (SOX7) by targeting its mRNA 3&#x2032;UTR to promote TGF-&#x3B2;1-mediated invasion and adhesion to fibronectin in A549 and HCC827 cells [<xref rid="B63-ijms-21-01193" ref-type="bibr">63</xref>].</p>
        </sec>
        <sec id="sec4dot1dot4-ijms-21-01193">
          <title>4.1.4. MiR-134 and miR-487b</title>
          <p>MiR-134 and miR-487b are both located on chromosome 14q32, and both of them can be activated by TGF-&#x3B2;1 during EMT progression in lung adenocarcinoma. Moreover, over-expressed miR-134 and miR-487b can promote TGF-&#x3B2;1-induced EMT by suppressing membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (MAGI2) (a multidomain scaffolding protein that can repress Smad3-induced transcriptional activity by interacting with Smad3 [<xref rid="B64-ijms-21-01193" ref-type="bibr">64</xref>]) in A549 cells [<xref rid="B65-ijms-21-01193" ref-type="bibr">65</xref>].</p>
        </sec>
        <sec id="sec4dot1dot5-ijms-21-01193">
          <title>4.1.5. MiR-330-3p</title>
          <p>MiR-330-3p is up-regulated in NSCLC tissues [<xref rid="B66-ijms-21-01193" ref-type="bibr">66</xref>]. In NCI-H1975 cells, miR-330-3p expression is very high, and miR-330-3p inhibitor transfection can obviously decrease its levels. Down-regulated miR-330-3p can increase E-cadherin and reduce vimentin, thus inhibiting TGF-&#x3B2;1-induced EMT. This indicates a positive relationship between miR-330-3p and TGF-&#x3B2;1-induced EMT [<xref rid="B67-ijms-21-01193" ref-type="bibr">67</xref>].</p>
        </sec>
        <sec id="sec4dot1dot6-ijms-21-01193">
          <title>4.1.6. MiR-1246</title>
          <p>MiR-1246 expression has been shown to be markedly increased in NSCLC and SCLC patients&#x2019; serum by quantitative real-time polymerase chain reaction (qRT-PCR). It can decrease E-cadherin, as well as increase vimentin and TGF-&#x3B2;, contributing to promoting EMT in A549 cells [<xref rid="B68-ijms-21-01193" ref-type="bibr">68</xref>].</p>
        </sec>
        <sec id="sec4dot1dot7-ijms-21-01193">
          <title>4.1.7. MiR-9-5p</title>
          <p>MiR-9-5p levels are higher in NSCLC tissues and cell lines compared to normal ones. It has been revealed that decreased receptor effects can abrogate TGF-&#x3B2; suppressive functions, thereby showing its oncogenic roles in NSCLC [<xref rid="B69-ijms-21-01193" ref-type="bibr">69</xref>,<xref rid="B70-ijms-21-01193" ref-type="bibr">70</xref>]. MiR-9-5p can bind to TGFBR2 mRNA and then attenuate its expression, subsequently facilitating A549 cells invasion and migration [<xref rid="B71-ijms-21-01193" ref-type="bibr">71</xref>].</p>
        </sec>
        <sec id="sec4dot1dot8-ijms-21-01193">
          <title>4.1.8. MiR-181b-5p</title>
          <p>Cancer stem cells (CSCs) possess self-renewal properties and have been demonstrated to be a small population of cells within lung cancer tissues, which can promote lung tumor metastasis [<xref rid="B72-ijms-21-01193" ref-type="bibr">72</xref>]. MiR-181b-5p can be obviously up-regulated by TGF-&#x3B2;1 in lung CSCs and A549 cells. It can suppress E-cadherin expression, thereby promoting EMT and eventually increasing invasion and metastasis in lung CSCs and A549 cells in vitro and <italic>in vivo</italic>. Moreover, up-regulated miR-181b-5p can predict poor outcomes in NSCLC patients [<xref rid="B73-ijms-21-01193" ref-type="bibr">73</xref>].</p>
        </sec>
        <sec id="sec4dot1dot9-ijms-21-01193">
          <title>4.1.9. MiR-23a</title>
          <p>MiR-23a is up-regulated in NSCLC cell lines, and can also be up-regulated by the TGF-&#x3B2;1/Smad2/3 signaling pathway. MiR-23a can target the 3&#x2019; UTR of <italic>CDH1</italic> (a gene that can encode E-cadherin) and then suppress E-cadherin expression, eventually enhancing TGF-&#x3B2;1-induced EMT in A549 cells. Further, miR-23a can also cause resistance to gefitinib [<xref rid="B74-ijms-21-01193" ref-type="bibr">74</xref>]. Accumulating studies have revealed that lung cancer cells can secrete exosomes into the extracellular environment to affect lung tumor cell invasion, migration, and metastasis. In this process, exosomes can carry several materials, such as DNA, nc-RNAs, and proteins [<xref rid="B75-ijms-21-01193" ref-type="bibr">75</xref>]. MiR-23a and &#x3B2;-catenin can be increased by TGF-&#x3B2;1 in A549 cells-derived exosomes, while E-cadherin is decreased (<xref ref-type="fig" rid="ijms-21-01193-f003">Figure 3</xref>). In addition, treatment with these exosomes can induce EMT in A549 cells [<xref rid="B76-ijms-21-01193" ref-type="bibr">76</xref>].</p>
        </sec>
      </sec>
      <sec id="sec4dot2-ijms-21-01193">
        <title>4.2. Negative Roles of miRNAs</title>
        <sec id="sec4dot2dot1-ijms-21-01193">
          <title>4.2.1. MiR-132</title>
          <p>In NSCLC tissues with lymphatic metastasis, the expression of miR-132 is found to be obviously lower than that in adjacent normal tissues. MiR-132 can suppress the TGF-&#x3B2;1/Smad2 signaling pathway and, moreover, reduce N-cadherin, ZEB1, Snail, and vimentin, leading to a repression of EMT, invasion, and migration in A549 cells [<xref rid="B77-ijms-21-01193" ref-type="bibr">77</xref>].</p>
        </sec>
        <sec id="sec4dot2dot2-ijms-21-01193">
          <title>4.2.2. MiR-203 and miR-145</title>
          <p>MiR-203 and miR-145 are reduced in NSCLC tissues and cell lines. Smad3 was predicted to be their target by PicTar and miRanda. Both miR-203 and miR-145 can interact with the 3&#x2032;UTR of Smad3 mRNA to decrease its levels, ultimately inhibiting TGF-&#x3B2;1-induced EMT and invasion in A549 and 95C cells [<xref rid="B78-ijms-21-01193" ref-type="bibr">78</xref>].</p>
        </sec>
        <sec id="sec4dot2dot3-ijms-21-01193">
          <title>4.2.3. MiR-205</title>
          <p>MiR-205 is down-regulated in NSCLC cell lines. MiR-205 can repress Smad4 by targeting its mRNA, subsequently impairing TGF-&#x3B2;/Smad4 signaling pathway-induced EMT in A549 cells [<xref rid="B79-ijms-21-01193" ref-type="bibr">79</xref>]. In addition, the transfection of miR-205 mimics into NCI-H1975 cells can significantly up-regulate its expressions. Over-expressed miR-205 can reduce vimentin and increase E-cadherin to suppress TGF-&#x3B2;-induced EMT [<xref rid="B67-ijms-21-01193" ref-type="bibr">67</xref>].</p>
        </sec>
        <sec id="sec4dot2dot4-ijms-21-01193">
          <title>4.2.4. MiR-124</title>
          <p>MiR-124 is decreased in NSCLC cell lines and tissues. TGF-&#x3B2; can increase DNMT3a expression, and then DNMT3a can bind to a miR-124 promoter, ultimately reducing miR-124 levels. MiR-124 can interact with Smad4 mRNA 3&#x2032;UTR to repress Smad4, ultimately inhibiting TGF-&#x3B2;-induced EMT [<xref rid="B80-ijms-21-01193" ref-type="bibr">80</xref>].</p>
        </sec>
        <sec id="sec4dot2dot5-ijms-21-01193">
          <title>4.2.5. MiR-422a</title>
          <p>MiR-422a is significantly down-regulated in NSCLC tissues compared to adjacent noncancerous lung tissues. MiR-422a can reduce sulfatase 2 (SULF2), which can inhibit the TGF-&#x3B2;1/Smad2/3 signaling pathway, eventually reducing EMT [<xref rid="B17-ijms-21-01193" ref-type="bibr">17</xref>]. Moreover, decreased miR-422a can also be regarded as a potential biomarker of lung cancer with lymphatic metastasis [<xref rid="B81-ijms-21-01193" ref-type="bibr">81</xref>].</p>
        </sec>
        <sec id="sec4dot2dot6-ijms-21-01193">
          <title>4.2.6. MiR-196b</title>
          <p>MiR-196b is diminished in NSCLC cell lines compared to normal cell lines. It can attenuate TGF-&#x3B2;1-induced EMT by decreasing N-cadherin, vimentin, ZEB1, and Snail in A549 cells [<xref rid="B82-ijms-21-01193" ref-type="bibr">82</xref>].</p>
        </sec>
        <sec id="sec4dot2dot7-ijms-21-01193">
          <title>4.2.7. MiR-940</title>
          <p>MiR-940 is declined in NSCLC tissues. It can target Snail mRNA 3&#x2032;UTR and repress Snail expression, thereby inhibiting TGF-&#x3B2;1-induced EMT in A549 and H226 cells [<xref rid="B83-ijms-21-01193" ref-type="bibr">83</xref>].</p>
        </sec>
        <sec id="sec4dot2dot8-ijms-21-01193">
          <title>4.2.8. MiR-22</title>
          <p>MiR-22 is obviously down-regulated in NSCLC cell lines. MiR-22 can be decreased by TGF-&#x3B2;1 in Anip973 and AGZY83-a cells. It can reduce Snail expression by binding to Snail mRNA 3&#x2032;UTR, thereby suppressing TGF-&#x3B2;1-induced EMT [<xref rid="B84-ijms-21-01193" ref-type="bibr">84</xref>].</p>
        </sec>
        <sec id="sec4dot2dot9-ijms-21-01193">
          <title>4.2.9. MiR-200 Family</title>
          <p>The miR-200 family consists of five members, including miR-200b, miR-200a, miR-429, miR-200c, and miR-141. The genes <italic>miR-200a</italic> and <italic>miR-200c</italic> can be repressed by TGF-&#x3B2; through over-expressing JARID2 and embryonic ectoderm development (EED) during EMT progression. <italic>miR-200a</italic> and <italic>miR-200c</italic> can inhibit ZEB1 and ZEB2 expression to repress EMT in A549 cells [<xref rid="B85-ijms-21-01193" ref-type="bibr">85</xref>,<xref rid="B86-ijms-21-01193" ref-type="bibr">86</xref>].</p>
        </sec>
        <sec id="sec4dot2dot10-ijms-21-01193">
          <title>4.2.10. MiR-145 and miR-497</title>
          <p>MiR-145 and miR-497 levels are decreased in NSCLC cell lines compared to normal cell lines. MiR-145 and miR-497 can inhibit metadherin (MTDH) by targeting its mRNA 3&#x2032;UTR, thereby inhibiting TGF-&#x3B2;-induced EMT, migration, and invasion in A549 and H1299 cells [<xref rid="B87-ijms-21-01193" ref-type="bibr">87</xref>].</p>
        </sec>
        <sec id="sec4dot2dot11-ijms-21-01193">
          <title>4.2.11. MiR-149</title>
          <p>The expression of miR-149 is higher in low-invasive NSCLC cells (A549 and Calu3 cells) than in high-invasive NSCLC cells (H1299 cells). MiR-149 can target forkhead Box M1 (FOXM1) mRNA 3&#x2019; UTR and repress its expression, eventually leading to a suppression of TGF-&#x3B2;1-induced EMT in A549 cells [<xref rid="B88-ijms-21-01193" ref-type="bibr">88</xref>].</p>
        </sec>
        <sec id="sec4dot2dot12-ijms-21-01193">
          <title>4.2.12. MiR-134</title>
          <p>MiR-134 expression is also higher in A549 and Calu1 cells than that in H1299 cells, and miR-134 can also repress forkhead Box M1 (FOXM1) to abrogate TGF-&#x3B2;1-induced EMT in A549 cells [<xref rid="B89-ijms-21-01193" ref-type="bibr">89</xref>].</p>
        </sec>
        <sec id="sec4dot2dot13-ijms-21-01193">
          <title>4.2.13. MiR-133</title>
          <p>MiR-133 is decreased in NSCLC cell lines. In A549 cells, miR-133 can down-regulate forkhead box Q1 (FOXQ1) to reduce TGF-&#x3B2; expression, finally suppressing EMT [<xref rid="B90-ijms-21-01193" ref-type="bibr">90</xref>].</p>
        </sec>
        <sec id="sec4dot2dot14-ijms-21-01193">
          <title>4.2.14. MiR-29c</title>
          <p>MiR-29c is down-regulated in NSCLC cell lines compared to normal cell lines. MiR-29c can be reduced by TGF-&#x3B2;1. MiR-29c can inhibit specificity protein 1 (Sp1), thereby repressing TGF-&#x3B2;1-induced EMT in A549 and 95C cells [<xref rid="B91-ijms-21-01193" ref-type="bibr">91</xref>].</p>
        </sec>
        <sec id="sec4dot2dot15-ijms-21-01193">
          <title>4.2.15. MiR-16</title>
          <p>MiR-16 is decreased in human NSCLC tissues compared to adjacent normal tissues. Autophagy is a complex biological process associated with the lysosomal degradation of cellular proteins and other cytoplasmic contents; it can also suppress NSCLC metastasis [<xref rid="B92-ijms-21-01193" ref-type="bibr">92</xref>,<xref rid="B93-ijms-21-01193" ref-type="bibr">93</xref>]. MiR-16 mimics were transfected into A549 cells to increase their expression levels. Up-regulated miR-16 can activate autophagy to inhibit TGF-&#x3B2;1-induced EMT [<xref rid="B94-ijms-21-01193" ref-type="bibr">94</xref>].</p>
        </sec>
        <sec id="sec4dot2dot16-ijms-21-01193">
          <title>4.2.16. MiR-129</title>
          <p>MiR-129 is down-regulated in NSCLC tissues [<xref rid="B95-ijms-21-01193" ref-type="bibr">95</xref>]. Overexpressed miR-129 can inhibit sex-determining region Y-box 4 (SOX4) expression, ultimately leading to abrogating TGF-&#x3B2;-induced EMT in A549 cells [<xref rid="B96-ijms-21-01193" ref-type="bibr">96</xref>]. Decreased miR-129 can predict a poor prognosis of NSCLC patients [<xref rid="B95-ijms-21-01193" ref-type="bibr">95</xref>].</p>
        </sec>
        <sec id="sec4dot2dot17-ijms-21-01193">
          <title>4.2.17. MiR-485-5p and miR-3127-5p</title>
          <p>MiR-485-5p and miR-3127-5p are both significantly lower in NSCLC tissues than in adjacent normal lung tissues. Both of them can impair TGF-&#x3B2;-induced EMT by preventing vimentin induction and increasing E-cadherin in A549 cells [<xref rid="B97-ijms-21-01193" ref-type="bibr">97</xref>,<xref rid="B98-ijms-21-01193" ref-type="bibr">98</xref>].</p>
        </sec>
        <sec id="sec4dot2dot18-ijms-21-01193">
          <title>4.2.18. MiR-3607-3p</title>
          <p>MiR-3607-3p expression is lower in NSCLC tissues than that in adjacent normal lung tissues. It can bind to the 3&#x2032;UTR of both TGFBR1 and cyclin E2 (CCNE2) mRNAs and then repress their expressions, thereby inhibiting NSCLC invasion and migration [<xref rid="B99-ijms-21-01193" ref-type="bibr">99</xref>].</p>
        </sec>
        <sec id="sec4dot2dot19-ijms-21-01193">
          <title>4.2.19. MiR-206 and miR-140</title>
          <p>MiR-206 and miR-140 are decreased in NSCLC tissues. Both miR-206 and miR-140 can interact with 3&#x2032;UTR of Smad3 mRNA to down-regulate its expression, thereby suppressing the TGF-&#x3B2;1 signaling pathway and ultimately abrogating A549 cell invasion, migration, and metastasis [<xref rid="B100-ijms-21-01193" ref-type="bibr">100</xref>].</p>
        </sec>
        <sec id="sec4dot2dot20-ijms-21-01193">
          <title>4.2.20. MiR-136</title>
          <p>MiR-136 has been found to be over-expressed in NSCLC tissues compared to adjacent normal lung tissues [<xref rid="B101-ijms-21-01193" ref-type="bibr">101</xref>]. In A549 and Calu-3 cells, miR-136 can reduce cell invasion and migration by reducing Smad2 and Smad3 expression, which may be involved in attenuating the TGF-&#x3B2; signaling pathway [<xref rid="B102-ijms-21-01193" ref-type="bibr">102</xref>].</p>
        </sec>
        <sec id="sec4dot2dot21-ijms-21-01193">
          <title>4.2.21. MiR-133a</title>
          <p>MiR-133a is also down-regulated in lung adenocarcinoma cells. MiR-133a can abrogate AKT signaling by reducing the TGF-&#x3B2;/TGFBR1 signal, contributing to suppressing A549 cell invasion and migration. In addition, low miR-133a expression can indicate a poor overall survival for lung cancer patients [<xref rid="B103-ijms-21-01193" ref-type="bibr">103</xref>].</p>
        </sec>
        <sec id="sec4dot2dot22-ijms-21-01193">
          <title>4.2.22. MiR-143</title>
          <p>MiR-143 is obviously reduced in NSCLC tissues compared to normal lung tissues. It can be stimulated by the TGF-&#x3B2;/Smads signaling pathway. MiR-143 can inhibit Smad3, CD44, and K-Ras expression, eventually repressing cell invasion and migration in A549 cells [<xref rid="B104-ijms-21-01193" ref-type="bibr">104</xref>].</p>
        </sec>
        <sec id="sec4dot2dot23-ijms-21-01193">
          <title>4.2.23. MiR-886-3p</title>
          <p>The miR-886-3p level is low in SCLC tissues and cell lines. MiR-886-3p can reduce cell invasion and migration by repressing TGF-&#x3B2;1 in NCI-H446 cells. In addition, down-regulated miR-886-3p can predict a shorter survival for SCLC patients [<xref rid="B105-ijms-21-01193" ref-type="bibr">105</xref>].</p>
        </sec>
        <sec id="sec4dot2dot24-ijms-21-01193">
          <title>4.2.24. MiR-138</title>
          <p>MiR-138 can be down-regulated by TGF-&#x3B2;1 in LC006 and LC021 cells. It can inhibit CSC formation by suppressing TGF-&#x3B2;1-induced EMT in primary lung cancer cells [<xref rid="B106-ijms-21-01193" ref-type="bibr">106</xref>].</p>
        </sec>
      </sec>
    </sec>
    <sec id="sec5-ijms-21-01193">
      <title>5. Roles of lncRNAs in TGF-&#x3B2; Signaling-Regulated Lung Cancer Metastasis</title>
      <sec id="sec5dot1-ijms-21-01193">
        <title>5.1. Positive Roles of lncRNAs</title>
        <sec id="sec5dot1dot1-ijms-21-01193">
          <title>5.1.1. LncRNA HCP5</title>
          <p>LncRNA histocompatibility leukocyte antigen complex P5 (HCP5) is highly expressed in lung adenocarcinoma cell lines, especially in current smokers and patients with mutated <italic>EGFR</italic> and <italic>KRAS</italic>. HCP5 can be induced by the TGF-&#x3B2;/Smad3 signaling pathway. In addition, it can augment Snail and Slug expression by attenuating miR-203, which can promote TGF-&#x3B2;/Smad3 signaling-induced EMT and invasion. Furthermore, HCP5 over-expression can indicate a poor prognosis for lung adenocarcinoma patients [<xref rid="B107-ijms-21-01193" ref-type="bibr">107</xref>].</p>
        </sec>
        <sec id="sec5dot1dot2-ijms-21-01193">
          <title>5.1.2. LncRNA NORAD</title>
          <p>LncRNA NORAD expression is higher in NSCLC tissues than in adjacent normal tissues [<xref rid="B108-ijms-21-01193" ref-type="bibr">108</xref>]. NORAD can stimulate Smad3 and importin &#x3B2;1 complex formation and then promote the TGF-&#x3B2;-induced translocation of the Smad2/3 complexes into the cell nucleus. NORAD ultimately increases EMT-related gene (<italic>SNAI1</italic> and <italic>FN1,</italic> which can encode Snail and fibronectin, respectively) expression to enhance TGF-&#x3B2;-induced EMT [<xref rid="B18-ijms-21-01193" ref-type="bibr">18</xref>].</p>
        </sec>
        <sec id="sec5dot1dot3-ijms-21-01193">
          <title>5.1.3. LncRNA XIST</title>
          <p>LncRNA X inactivate-specific transcript (XIST) is up-regulated in NSCLC tissues. On the one hand, XIST can bind to miR-137 and decrease its expression, thereby suppressing miR-137&#x2032;s inhibitory roles in TGF-&#x3B2;1-induced EMT [<xref rid="B20-ijms-21-01193" ref-type="bibr">20</xref>]. On the other hand, it can act as a kind of miRNA sponge to reduce miR-367 and miR-141 expression, thereby increasing ZEB2 [<xref rid="B19-ijms-21-01193" ref-type="bibr">19</xref>]. Through these two mechanisms, XIST can facilitate TGF-&#x3B2;1-induced EMT in A549 cells [<xref rid="B19-ijms-21-01193" ref-type="bibr">19</xref>,<xref rid="B20-ijms-21-01193" ref-type="bibr">20</xref>].</p>
        </sec>
        <sec id="sec5dot1dot4-ijms-21-01193">
          <title>5.1.4. LncRNA linc00673</title>
          <p>LncRNA linc00673 is up-regulated in NSCLC tissues and cell lines. It can also be elevated by TGF-&#x3B2;. MiR-150-5p can target ZEB1 mRNA 3&#x2032;UTR and attenuate its expression. Linc00673 can act as a competing endogenous RNA (ceRNA) that can suppress the effect of miR-150-5p on ZEB1, ultimately potentiating TGF-&#x3B2;-induced EMT, invasion, and migration in A549 and H1975 cells. Furthermore, up-regulated linc00673 can indicate poor survival for NSCLC patients [<xref rid="B109-ijms-21-01193" ref-type="bibr">109</xref>].</p>
        </sec>
        <sec id="sec5dot1dot5-ijms-21-01193">
          <title>5.1.5. LncRNA MEG3</title>
          <p>LncRNA MEG3 can be overexpressed by TGF-&#x3B2; during EMT progression. In A549 and LC-2/ad cells, MEG3 shRNA can silence its expression, and MEG3 knockdown can abrogate TGF-&#x3B2;-induced actin stress fiber formation, which can inhibit EMT. MEG3 cDNA can increase its levels, and MEG3 over-expression can not only decrease the expression of genes <italic>CDH1</italic>, <italic>miR-200a,</italic> and <italic>miR-200c</italic> but can also increase the expression of genes <italic>ZEB1</italic> and <italic>ZEB2</italic> through the recruitment of JARID2 and the enhancer of zeste homologue 2 (EZH2) [<xref rid="B110-ijms-21-01193" ref-type="bibr">110</xref>].</p>
        </sec>
        <sec id="sec5dot1dot6-ijms-21-01193">
          <title>5.1.6. LncRNA MEG8</title>
          <p>LncRNA MEG8 can also be up-regulated by TGF-&#x3B2; during EMT progression. MEG8 can interact with EZH2 and can subsequently down-regulate <italic>CDH1</italic> expression. At the same time, MEG8 can up-regulate <italic>SNAI1</italic> and <italic>SNAI2</italic> (a gene that can encode Slug) expression by repressing the <italic>miR-34a</italic> and <italic>miR-203</italic> genes in A549 and LC-2/ad cells. It has also been revealed that neither MEG8 nor MEG3 can exclusively lead to EMT without TGF-&#x3B2;. However, the co-expression of MEG8 and MEG3 can induce EMT in the absence of TGF-&#x3B2; [<xref rid="B111-ijms-21-01193" ref-type="bibr">111</xref>].</p>
        </sec>
        <sec id="sec5dot1dot7-ijms-21-01193">
          <title>5.1.7. LncRNA ATB</title>
          <p>LncRNA activated by TGF-&#x3B2; (ATB) is obviously over-expressed in NSCLC tissues. ATB can accelerate NSCLC migration by abolishing E-cadherin and increasing N-cadherin [<xref rid="B112-ijms-21-01193" ref-type="bibr">112</xref>]. Additionally, ATB can enhance TGF-&#x3B2;1-induced EMT by down-regulating miR-494 [<xref rid="B113-ijms-21-01193" ref-type="bibr">113</xref>]. ATB can also inhibit miR-494 to activate the AKT and the JAK/STAT3 pathways that are required for TGF-&#x3B2;-induced EMT [<xref rid="B38-ijms-21-01193" ref-type="bibr">38</xref>]. Notably, high lncRNA-ATB expression can predict poor outcomes for lung cancer patients [<xref rid="B114-ijms-21-01193" ref-type="bibr">114</xref>].</p>
        </sec>
        <sec id="sec5dot1dot8-ijms-21-01193">
          <title>5.1.8. LncRNA TBILA</title>
          <p>LncRNA TGF-&#x3B2;-induced lncRNA (TBILA) is highly expressed in NSCLC tissues and can be induced by the TGF-&#x3B2;1/Smad2/3 signaling pathway. TBILA can not only activate RhoA by up-regulating human germinal center-associated lymphoma (HGAL) (a TGF-&#x3B2;-induced gene) but can also increase S100A7/c-Jun activation domain-binding protein 1 (JAB1) activity by interacting with S100A7, eventually facilitating invasion and migration in A549 cells [<xref rid="B115-ijms-21-01193" ref-type="bibr">115</xref>].</p>
        </sec>
        <sec id="sec5dot1dot9-ijms-21-01193">
          <title>5.1.9. Lnc-MMP2-2</title>
          <p>Lnc-MMP2-2 is over-expressed in lung cancer tissues, and it can be obviously increased in the exosomes derived from A549 cells by TGF-&#x3B2; (<xref ref-type="fig" rid="ijms-21-01193-f003">Figure 3</xref>). On the one hand, exosomal lnc-MMP2-2 can increase N-cadherin and vimentin and decrease E-cadherin to facilitate invasion and migration. On the other hand, it can inhibit occludin and zonula occludens-1 (Zo-1) to impair vascular tight junctions, thus increasing vascular permeability. Exosomal lnc-MMP2-2 can also increase MMP2, which can accelerate metastasis [<xref rid="B116-ijms-21-01193" ref-type="bibr">116</xref>].</p>
        </sec>
        <sec id="sec5dot1dot10-ijms-21-01193">
          <title>5.1.10. LncRNA AWPPH</title>
          <p>LncRNA AWPPH expression was estimated to be higher in the blood of lung cancer patients than in normal people by qRT-PCR. AWPPH can stimulate TGF-&#x3B2;1 protein expression to promote NSCLC migration and invasion. Moreover, high AWPPH can indicate the postoperative distant recurrence of NSCLC patients [<xref rid="B117-ijms-21-01193" ref-type="bibr">117</xref>].</p>
        </sec>
        <sec id="sec5dot1dot11-ijms-21-01193">
          <title>5.1.11. LncRNA CASC11</title>
          <p>LncRNA CASC11 has been shown by qRT-PCR to be significantly increased in the plasma of SCLC patients. CASC11 can promote SCLC stemness by up-regulating TGF-&#x3B2;1, eventually increasing the number of lung CSCs. Further, CASC11 up-regulation can reveal the poor prognosis of SCLC patients [<xref rid="B118-ijms-21-01193" ref-type="bibr">118</xref>].</p>
        </sec>
      </sec>
      <sec id="sec5dot2-ijms-21-01193">
        <title>5.2. Negative Roles of lncRNAs</title>
        <sec id="sec5dot2dot1-ijms-21-01193">
          <title>5.2.1. LncRNA HAND2-AS1</title>
          <p>LncRNA HAND2-AS1 is down-regulated in NSCLC tissues. HAND2-AS1 can inhibit migration, invasion, and stemness by reducing TGF-&#x3B2;1 expression, as well as phosphorylated Smad2 and Smad3 levels, in NSCLC [<xref rid="B119-ijms-21-01193" ref-type="bibr">119</xref>].</p>
        </sec>
        <sec id="sec5dot2dot2-ijms-21-01193">
          <title>5.2.2. LncRNA linc01186</title>
          <p>LncRNA linc01186 is decreased in NSCLC tissues. It can be repressed by the TGF-&#x3B2;1/Smad3 signaling pathway. Linc01186 can inhibit cell invasion and migration by repressing EMT [<xref rid="B120-ijms-21-01193" ref-type="bibr">120</xref>].</p>
        </sec>
        <sec id="sec5dot2dot3-ijms-21-01193">
          <title>5.2.3. LncRNA LINP1</title>
          <p>LncRNA in nonhomologous end joining (NHEJ) pathway 1 (LINP1) is also reduced by TGF-&#x3B2;1/Smad4. LINP1 can increase E-cadherin and downregulate vimentin and Snail to abrogate TGF-&#x3B2;1-induced EMT and cell invasion [<xref rid="B121-ijms-21-01193" ref-type="bibr">121</xref>].</p>
        </sec>
        <sec id="sec5dot2dot4-ijms-21-01193">
          <title>5.2.4. LncRNA ANCR</title>
          <p>LncRNA ANCR has been shown by qRT-PCR to be markedly decreased in the plasma of NSCLC patients. Moreover, it can decrease TGF-&#x3B2;1 expression and thus inhibit NSCLC migration and invasion. Low ANCR expression can reveal the shorter overall survival time of patients than that of patients with high ANCR expression [<xref rid="B122-ijms-21-01193" ref-type="bibr">122</xref>].</p>
        </sec>
        <sec id="sec5dot2dot5-ijms-21-01193">
          <title>5.2.5. LncRNA NKILA</title>
          <p>LncRNA NF-&#x3BA;B Interacting LncRNA (NKILA) is down-regulated in NSCLC tissues. NKILA can be increased by TGF-&#x3B2;/Smads pathways. It can suppress invasion and migration by inhibiting NF-&#x3BA;B activation and then repressing Snail-mediated EMT [<xref rid="B123-ijms-21-01193" ref-type="bibr">123</xref>].</p>
        </sec>
      </sec>
    </sec>
    <sec id="sec6-ijms-21-01193">
      <title>6. MiRNA Sponges Participate in TGF-&#x3B2; Signaling-Regulated Lung Cancer Metastasis</title>
      <p>LncRNAs, ceRNAs, and circular RNAs (circRNAs) have been regarded as miRNA sponges to inhibit miRNAs in lung cancer. LncRNA has MREs, and it can influence the target gene downstream of the miRNAs by repressing them [<xref rid="B124-ijms-21-01193" ref-type="bibr">124</xref>]. CeRNAs can regulate gene expression by competitively binding to miRNA through MREs, thereby suppressing the interactions between miRNA and its targeted mRNA. CeRNA is also essential for miRNA and lncRNA regulatory networks [<xref rid="B125-ijms-21-01193" ref-type="bibr">125</xref>]. CircRNAs, belonging to endogenous nc-RNAs, possess closed-loop structures without a 5&#x2019; end cap and a 3&#x2019; end poly tail structure. CircRNA has several miRNA-binding sites to adsorb miRNA, subsequently counteracting miRNA&#x2019;s effects on its target gene expression [<xref rid="B126-ijms-21-01193" ref-type="bibr">126</xref>]. Additionally, circRNAs can also work as ceRNAs in lung cancer. CeRNAs and circRNAs can regulate lung cancer migration, invasion, and metastasis [<xref rid="B127-ijms-21-01193" ref-type="bibr">127</xref>,<xref rid="B128-ijms-21-01193" ref-type="bibr">128</xref>].</p>
      <sec id="sec6dot1-ijms-21-01193">
        <title>6.1. CeRNA</title>
        <sec id="sec6dot1dot1-ijms-21-01193">
          <title>6.1.1. CeRNA MYEOV</title>
          <p>The ceRNA myeloma overexpressed gene (MYEOV) is significantly over-expressed in NSCLC tissues compared to adjacent normal tissues. MiR-30c-2-3p can inhibit TGFBR2 and Ubiquitin specific protease 15 (USP15) (a deubiquitinating enzyme that can promote TGF-&#x3B2; signaling) expression by targeting their mRNA 3&#x2032;UTRs. MYEOV can bind to and then suppress miR-30c-2-3p, eventually contributing to activating TGF-&#x3B2; signaling and potentiating invasion and metastasis in NSCLC [<xref rid="B129-ijms-21-01193" ref-type="bibr">129</xref>].</p>
        </sec>
        <sec id="sec6dot1dot2-ijms-21-01193">
          <title>6.1.2. CeRNA HMGA2</title>
          <p>CeRNA HMGA2 is up-regulated in metastatic lung adenocarcinoma. HMGA2 can increase TGFBR3 expression by repressing miRNA let-7, which can also enhance the TGF-&#x3B2; signaling pathway, ultimately promoting invasion and metastasis in NSCLC [<xref rid="B130-ijms-21-01193" ref-type="bibr">130</xref>].</p>
        </sec>
      </sec>
      <sec id="sec6dot2-ijms-21-01193">
        <title>6.2. CircRNA</title>
        <p>The circRNA CircPTK2 level is lower in NSCLC tissues than in normal lung tissues. It can be inhibited by TGF-&#x3B2;1 during EMT progression. MiR-429 and miR-200b-3p can repress transcriptional intermediary factor 1 &#x3B3; (TIF1&#x3B3;) (a regulator that can suppress TGF-&#x3B2;/Smad signaling [<xref rid="B131-ijms-21-01193" ref-type="bibr">131</xref>]) expression. CircPTK2 can bind to miR-429 and miR-200b-3p, subsequently attenuating their effects and resulting in abrogating TGF-&#x3B2;1-induced EMT, migration, and invasion in A549 cells [<xref rid="B132-ijms-21-01193" ref-type="bibr">132</xref>].</p>
      </sec>
    </sec>
    <sec id="sec7-ijms-21-01193">
      <title>7. Targeted Therapy</title>
      <p>Although traditional lung cancer therapies, such as surgical resection, chemotherapy, and radiotherapy, have made great progress, they still face some limitations. For example, drug resistance and lung cancer distant metastasis can usually influence the therapeutic effects of a treatment. As a result, it is necessary to develop new strategies. MiRNAs and lncRNAs participate in substantial lung cancer progression, and we may be able to use them as treatment targets.</p>
      <sec id="sec7dot1-ijms-21-01193">
        <title>7.1. Curcumin</title>
        <p>Curcumin, isolated from <italic>Curcuma longa</italic>, possesses anti-cancer effects and chemopreventive properties. Curcumin can significantly inhibit several miRNA-associated pathways, such as the MAPK, TGF-&#x3B2;, and Wnt signaling pathways, contributing to suppressing invasion and migration in A549 cells [<xref rid="B133-ijms-21-01193" ref-type="bibr">133</xref>].</p>
      </sec>
      <sec id="sec7dot2-ijms-21-01193">
        <title>7.2. Carboplatin</title>
        <p>Carboplatin can interact with ifosfamide and paclitaxel and possesses fewer non-hematologic toxicities than cisplatin (DDP). Carboplatin is a chemotherapeutic drug widely used to treat SCLC and NSCLC in order to improve overall survival [<xref rid="B134-ijms-21-01193" ref-type="bibr">134</xref>]. Carboplatin can suppress miR-21 to increase Smad7 expression. Then, up-regulated Smad7 can inhibit the TGF-&#x3B2;/Smads signaling pathways, thereby suppressing TGF-&#x3B2;-mediated invasion in A549 cells [<xref rid="B135-ijms-21-01193" ref-type="bibr">135</xref>].</p>
      </sec>
      <sec id="sec7dot3-ijms-21-01193">
        <title>7.3. DDP</title>
        <p>DDP is also extensively used to deal with lung cancer. MiR-181b is decreased in NSCLC cells. It can target TGFBR1 mRNA 3&#x2032;UTR and repress its expression, thus abrogating the TGF-&#x3B2; signal and eventually increasing DDP chemosensitivity in NSCLC cells [<xref rid="B136-ijms-21-01193" ref-type="bibr">136</xref>]. MiR-17, miR-20a, and miR-20b are all down-regulated in A549/DDP cells (DDP-resistant A549 cells). They can attenuate the TGF-&#x3B2; signal pathway by inhibiting TGFBR1, thereby reducing migration and increasing DDP sensitivity in A549/DDP cells [<xref rid="B137-ijms-21-01193" ref-type="bibr">137</xref>].</p>
      </sec>
      <sec id="sec7dot4-ijms-21-01193">
        <title>7.4. DAC</title>
        <p>Decitabine (DAC) is a deoxyribonucleotide and can abrogate DNA methylation. Functionally, DAC promotes demethylation of the miR-200 promoter to increase the levels of miR-200c and miR-200a, which can repress <italic>ZEB1</italic> and <italic>ZEB2</italic> expression, leading to decreasing TGF-&#x3B2;1-induced EMT and metastasis in PC9 cells [<xref rid="B138-ijms-21-01193" ref-type="bibr">138</xref>].</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="sec8-ijms-21-01193">
      <title>8. Discussion and Conclusions</title>
      <p>Lung cancer is the most common cancer in men and the second most common in women after breast cancer. The low overall survival rate of lung cancer patients is usually correlated with distant organ metastasis. MiRNAs and lncRNAs are demonstrated to be oncogenes or suppressors by targeting mRNA 3&#x2032;UTR in lung cancer development. Currently, miRNAs and lncRNAs are widely used to explore lung cancer&#x2019;s metastatic mechanisms, and these two nc-RNAs are increasingly used as biomarkers to predict the outcomes of lung cancer patients. TGF-&#x3B2; is involved in many cancers, and TGF-&#x3B2; signaling pathways have also been extensively confirmed to play pivotal roles in lung cancer metastasis. Interestingly, we found that Carboplatin, the first-line therapy used to treat metastatic lung cancer, suppresses TGF-&#x3B2; signaling-regulated lung cancer metastasis by repressing miR-21 [<xref rid="B135-ijms-21-01193" ref-type="bibr">135</xref>]. This result suggests a potential treatment strategy involving miRNAs and TGF-&#x3B2; signaling for lung cancer metastasis. Considering the widespread attention attracted by the rational design of miRNA/lncRNA-targeted drugs against lung cancer, we have summarized and discussed the relationships between these two nc-RNAs and TGF-&#x3B2; signaling pathways in lung cancer metastasis. We hope that this review will provide new ideas for more clinical therapies like Carboplatin, thereby allowing us to treat lung cancer more effectively.</p>
      <p>In the current review, we discussed how miRNAs and lncRNAs can exert positive (<xref rid="ijms-21-01193-t001" ref-type="table">Table 1</xref>) and negative (<xref rid="ijms-21-01193-t002" ref-type="table">Table 2</xref>) influences on TGF-&#x3B2; signaling-regulated lung cancer metastasis. The positive roles of miRNAs and lncRNAs can be concluded as follows: miR-93 [<xref rid="B59-ijms-21-01193" ref-type="bibr">59</xref>], miR-128-3p [<xref rid="B61-ijms-21-01193" ref-type="bibr">61</xref>], miR-9 [<xref rid="B62-ijms-21-01193" ref-type="bibr">62</xref>], miR-134, miR-487b [<xref rid="B65-ijms-21-01193" ref-type="bibr">65</xref>], miR-330-3p [<xref rid="B67-ijms-21-01193" ref-type="bibr">67</xref>], miR-1246 [<xref rid="B68-ijms-21-01193" ref-type="bibr">68</xref>], miR-23a [<xref rid="B74-ijms-21-01193" ref-type="bibr">74</xref>], HCP5 [<xref rid="B107-ijms-21-01193" ref-type="bibr">107</xref>], NORAD [<xref rid="B18-ijms-21-01193" ref-type="bibr">18</xref>], XIST [<xref rid="B19-ijms-21-01193" ref-type="bibr">19</xref>,<xref rid="B20-ijms-21-01193" ref-type="bibr">20</xref>], linc00673 [<xref rid="B109-ijms-21-01193" ref-type="bibr">109</xref>], MEG3 [<xref rid="B110-ijms-21-01193" ref-type="bibr">110</xref>], MEG8 [<xref rid="B111-ijms-21-01193" ref-type="bibr">111</xref>], and ATB [<xref rid="B113-ijms-21-01193" ref-type="bibr">113</xref>] can enhance TGF-&#x3B2; signaling-induced EMT. MiR-9 [<xref rid="B63-ijms-21-01193" ref-type="bibr">63</xref>], miR-9-5p [<xref rid="B71-ijms-21-01193" ref-type="bibr">71</xref>], ATB [<xref rid="B112-ijms-21-01193" ref-type="bibr">112</xref>], TBILA [<xref rid="B115-ijms-21-01193" ref-type="bibr">115</xref>] lnc-MMP2-2 [<xref rid="B116-ijms-21-01193" ref-type="bibr">116</xref>], and AWPPH [<xref rid="B117-ijms-21-01193" ref-type="bibr">117</xref>] can accelerate TGF-&#x3B2; signaling-mediated lung cancer cell migration and invasion. Lnc-MMP2-2 can also increase vascular permeability [<xref rid="B116-ijms-21-01193" ref-type="bibr">116</xref>]. TGF-&#x3B2;1-increased miR-181b-5p can facilitate lung CSCs&#x2019; metastatic abilities by inducing EMT [<xref rid="B73-ijms-21-01193" ref-type="bibr">73</xref>]. CASC11 can augment TGF-&#x3B2;1 to promote lung cancer cell stemness [<xref rid="B139-ijms-21-01193" ref-type="bibr">139</xref>]. TGF-&#x3B2;-induced miR-183 can down-regulate MICA and MICB to make NSCLC cells escape from immune attacks mediated by circulating immune cells (i.e., natural killer (NK) cells and CD8+ T cells) expressing NKG2D [<xref rid="B52-ijms-21-01193" ref-type="bibr">52</xref>]. Additionally, in the NSCLC microenvironment, tumor-derived TGF-&#x3B2; can also increase miR-183, which can decrease DNAX activating protein 12 kDa (DAP12) (a protein required for NK cell cytotoxicity functions), ultimately inhibiting tumor-infiltrating NK cell activities to promote immunosuppression [<xref rid="B140-ijms-21-01193" ref-type="bibr">140</xref>], while miRNAs and lncRNAs can also exhibit opposite effects on lung cancer metastasis. MiR-132 [<xref rid="B77-ijms-21-01193" ref-type="bibr">77</xref>], miR-203, miR-145 [<xref rid="B78-ijms-21-01193" ref-type="bibr">78</xref>], miR-205 [<xref rid="B79-ijms-21-01193" ref-type="bibr">79</xref>], miR-124 [<xref rid="B80-ijms-21-01193" ref-type="bibr">80</xref>], miR-422a [<xref rid="B17-ijms-21-01193" ref-type="bibr">17</xref>], miR-196b [<xref rid="B82-ijms-21-01193" ref-type="bibr">82</xref>], miR-940 [<xref rid="B83-ijms-21-01193" ref-type="bibr">83</xref>], miR-22 [<xref rid="B84-ijms-21-01193" ref-type="bibr">84</xref>], <italic>miR-200a</italic>, <italic>miR-200c</italic> [<xref rid="B85-ijms-21-01193" ref-type="bibr">85</xref>,<xref rid="B86-ijms-21-01193" ref-type="bibr">86</xref>], miR-145, miR-497 [<xref rid="B87-ijms-21-01193" ref-type="bibr">87</xref>], miR-149 [<xref rid="B88-ijms-21-01193" ref-type="bibr">88</xref>], miR-134 [<xref rid="B89-ijms-21-01193" ref-type="bibr">89</xref>], miR-133 [<xref rid="B90-ijms-21-01193" ref-type="bibr">90</xref>], miR-29c [<xref rid="B91-ijms-21-01193" ref-type="bibr">91</xref>], miR-16 [<xref rid="B94-ijms-21-01193" ref-type="bibr">94</xref>], miR-129 [<xref rid="B96-ijms-21-01193" ref-type="bibr">96</xref>], miR-485-5p [<xref rid="B97-ijms-21-01193" ref-type="bibr">97</xref>], miR-3127-5p [<xref rid="B98-ijms-21-01193" ref-type="bibr">98</xref>], and LINP1 [<xref rid="B121-ijms-21-01193" ref-type="bibr">121</xref>] can suppress TGF-&#x3B2; signaling-regulated EMT. MiR-3607-3p [<xref rid="B99-ijms-21-01193" ref-type="bibr">99</xref>], miR-206, miR-140 [<xref rid="B100-ijms-21-01193" ref-type="bibr">100</xref>], miR-136 [<xref rid="B102-ijms-21-01193" ref-type="bibr">102</xref>], miR-133a [<xref rid="B103-ijms-21-01193" ref-type="bibr">103</xref>], miR-143 [<xref rid="B104-ijms-21-01193" ref-type="bibr">104</xref>], miR-886-3p [<xref rid="B105-ijms-21-01193" ref-type="bibr">105</xref>], HAND2-AS1 [<xref rid="B119-ijms-21-01193" ref-type="bibr">119</xref>], linc01186 [<xref rid="B120-ijms-21-01193" ref-type="bibr">120</xref>], ANCR [<xref rid="B122-ijms-21-01193" ref-type="bibr">122</xref>], and NKILA [<xref rid="B123-ijms-21-01193" ref-type="bibr">123</xref>] can repress TGF-&#x3B2; signaling-modulated lung cancer cell migration and invasion. MiR-138 can reduce lung CSC formation by abrogating TGF-&#x3B2;1-induced EMT [<xref rid="B106-ijms-21-01193" ref-type="bibr">106</xref>]. HAND2-AS1 can attenuate lung cancer cell stemness by inhibiting the TGF-&#x3B2;1/Smad2/3 signaling pathway [<xref rid="B119-ijms-21-01193" ref-type="bibr">119</xref>]. During these progressions, we found the following similarities between miRNAs and lncRNAs (<xref rid="ijms-21-01193-t001" ref-type="table">Table 1</xref>, <xref rid="ijms-21-01193-t002" ref-type="table">Table 2</xref>, and <xref ref-type="fig" rid="ijms-21-01193-f003">Figure 3</xref>):</p>
      <p>They can be increased or decreased via TGF-&#x3B2; signaling. MiR-9 [<xref rid="B62-ijms-21-01193" ref-type="bibr">62</xref>,<xref rid="B63-ijms-21-01193" ref-type="bibr">63</xref>], miR-23a [<xref rid="B74-ijms-21-01193" ref-type="bibr">74</xref>,<xref rid="B76-ijms-21-01193" ref-type="bibr">76</xref>], miR-134, miR-487b [<xref rid="B65-ijms-21-01193" ref-type="bibr">65</xref>], miR-181b-5p [<xref rid="B73-ijms-21-01193" ref-type="bibr">73</xref>], miR-143 [<xref rid="B104-ijms-21-01193" ref-type="bibr">104</xref>], HCP5 [<xref rid="B107-ijms-21-01193" ref-type="bibr">107</xref>], linc00673 [<xref rid="B109-ijms-21-01193" ref-type="bibr">109</xref>], MEG3 [<xref rid="B110-ijms-21-01193" ref-type="bibr">110</xref>], MEG8 [<xref rid="B111-ijms-21-01193" ref-type="bibr">111</xref>], ATB [<xref rid="B113-ijms-21-01193" ref-type="bibr">113</xref>], TBILA [<xref rid="B115-ijms-21-01193" ref-type="bibr">115</xref>], lnc-MMP2-2 [<xref rid="B116-ijms-21-01193" ref-type="bibr">116</xref>], and NKILA [<xref rid="B123-ijms-21-01193" ref-type="bibr">123</xref>] can be increased by TGF-&#x3B2; signaling, while <italic>miR-200a</italic>, <italic>miR-200c</italic> [<xref rid="B85-ijms-21-01193" ref-type="bibr">85</xref>,<xref rid="B86-ijms-21-01193" ref-type="bibr">86</xref>], miR-138 [<xref rid="B106-ijms-21-01193" ref-type="bibr">106</xref>], linc01186 [<xref rid="B120-ijms-21-01193" ref-type="bibr">120</xref>], and LINP1 [<xref rid="B121-ijms-21-01193" ref-type="bibr">121</xref>] can be decreased by TGF-&#x3B2; signaling.
<list list-type="simple"><list-item><label>&#x27A3;</label><p>They can promote or suppress TGF-&#x3B2;/Smads pathways or other non-Smad pathways. MiR-93 [<xref rid="B59-ijms-21-01193" ref-type="bibr">59</xref>] and NORAD [<xref rid="B18-ijms-21-01193" ref-type="bibr">18</xref>] can promote the TGF-&#x3B2;/Smads signaling pathways. ATB can promote the AKT signal and JAK/STAT3 signal [<xref rid="B113-ijms-21-01193" ref-type="bibr">113</xref>]. MiR-132 [<xref rid="B77-ijms-21-01193" ref-type="bibr">77</xref>], miR-422a [<xref rid="B17-ijms-21-01193" ref-type="bibr">17</xref>], miR-206, miR-140 [<xref rid="B100-ijms-21-01193" ref-type="bibr">100</xref>], and HAND2-AS1 [<xref rid="B119-ijms-21-01193" ref-type="bibr">119</xref>] can repress the TGF-&#x3B2;/Smads signaling pathways. MiR-133a [<xref rid="B103-ijms-21-01193" ref-type="bibr">103</xref>] and NKILA [<xref rid="B123-ijms-21-01193" ref-type="bibr">123</xref>] can repress the TGF-&#x3B2;/AKT and NF-&#x3BA;B/Snail pathway, respectively.</p></list-item><list-item><label>&#x27A3;</label><p>They can promote or inhibit lung CSC formation. CASC11 can promote lung CSC formation [<xref rid="B118-ijms-21-01193" ref-type="bibr">118</xref>], while miR-138 [<xref rid="B106-ijms-21-01193" ref-type="bibr">106</xref>] and HAND2-AS1 [<xref rid="B119-ijms-21-01193" ref-type="bibr">119</xref>] can inhibit lung CSC formation.</p></list-item><list-item><label>&#x27A3;</label><p>They can be up-regulated in TGF-&#x3B2;-mediated exosomes, including miR-23a [<xref rid="B76-ijms-21-01193" ref-type="bibr">76</xref>] and lnc-MMP2-2 [<xref rid="B116-ijms-21-01193" ref-type="bibr">116</xref>].</p></list-item></list></p>
      <p>MiRNAs and lncRNAs can be detected in biological fluids through a biopsy of liquids, such as whole blood (lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) [<xref rid="B141-ijms-21-01193" ref-type="bibr">141</xref>] and miRNA-182-5p [<xref rid="B142-ijms-21-01193" ref-type="bibr">142</xref>]), serum (lncRNA linc00342 [<xref rid="B143-ijms-21-01193" ref-type="bibr">143</xref>], MEG3 [<xref rid="B144-ijms-21-01193" ref-type="bibr">144</xref>], miR-96 [<xref rid="B145-ijms-21-01193" ref-type="bibr">145</xref>] and miR-30a-5p [<xref rid="B146-ijms-21-01193" ref-type="bibr">146</xref>]), plasma (lncRNA linc00152 [<xref rid="B147-ijms-21-01193" ref-type="bibr">147</xref>], MALAT1 [<xref rid="B148-ijms-21-01193" ref-type="bibr">148</xref>], miR-145 [<xref rid="B149-ijms-21-01193" ref-type="bibr">149</xref>], miR-30b [<xref rid="B150-ijms-21-01193" ref-type="bibr">150</xref>], miR-25 [<xref rid="B151-ijms-21-01193" ref-type="bibr">151</xref>] and miR-425-3p [<xref rid="B152-ijms-21-01193" ref-type="bibr">152</xref>]), sputum (lncRNA HOTAIR, H19 [<xref rid="B153-ijms-21-01193" ref-type="bibr">153</xref>], miR-21 and miR-210 [<xref rid="B154-ijms-21-01193" ref-type="bibr">154</xref>]), and pleural effusion (MALAT1 [<xref rid="B155-ijms-21-01193" ref-type="bibr">155</xref>] and miR-200 family [<xref rid="B156-ijms-21-01193" ref-type="bibr">156</xref>]) in lung cancer. Furthermore, miRNAs can also be found in bronchoalveolar lavage fluid (miR-126 and miR-Let-7a [<xref rid="B157-ijms-21-01193" ref-type="bibr">157</xref>]). Both lncRNAs and miRNAs are usually dysregulated in lung cancer and are closely related to cancer metastasis. For instance, miR-25 is up-regulated in NSCLC tissues and cell lines and can repress large tumor suppressor homology 2 (LATS2) and then increase the yes-associated protein (YAP), ultimately contributing to promoting A549 cells migration and invasion [<xref rid="B158-ijms-21-01193" ref-type="bibr">158</xref>]. Moreover, high plasma miR-25 levels can indicate a poor prognosis for NSCLC patients [<xref rid="B151-ijms-21-01193" ref-type="bibr">151</xref>]. MiR-96 is elevated in the serum-derived exosomes of lung cancer patients. MiR-96 can suppress LIM-domain only protein 7 (LMO7) expression, thereby promoting A549 cell proliferation, migration, and DDP resistance. In addition, increasing serum exosomal miR-96 can predict lung cancer lymph node metastasis [<xref rid="B145-ijms-21-01193" ref-type="bibr">145</xref>]. MiR-21-5p is highly expressed in NSCLC tissues. It can decrease E-cadherin and increase MMP9 and vimentin, which can facilitate A549 cell invasion and migration [<xref rid="B159-ijms-21-01193" ref-type="bibr">159</xref>]. Further, high plasma miR-21 can reveal the distant metastasis of NSCLC patients [<xref rid="B160-ijms-21-01193" ref-type="bibr">160</xref>]. The expression of MALAT1 is significantly high in NSCLC tissues and cell lines [<xref rid="B161-ijms-21-01193" ref-type="bibr">161</xref>]. MALAT1 can enhance A549 cell invasion and migration by repressing miR-200a-3p [<xref rid="B162-ijms-21-01193" ref-type="bibr">162</xref>]. High serum exosomal MALAT1 could be an indicator for lymphatic metastasis in NSCLC patients [<xref rid="B163-ijms-21-01193" ref-type="bibr">163</xref>]. Linc00152 is up-regulated in lung adenocarcinoma tissues and can enhance H1299 and H1975 cell migration and invasion [<xref rid="B164-ijms-21-01193" ref-type="bibr">164</xref>]. Additionally, increased plasma linc00152 levels can indicate recurrence in NSCLC patients [<xref rid="B147-ijms-21-01193" ref-type="bibr">147</xref>]. Linc00342 is up-regulated in NSCLC tissues and cell lines. Linc00342 can increase cell invasion and migration by inhibiting miR-203a-3p in NCI-H1299 and NCI-H460 cells [<xref rid="B165-ijms-21-01193" ref-type="bibr">165</xref>], and high serum linc00342 can act as a better biomarker to diagnose NSCLC than CYFRA 21-1 (a sensitive factor that can diagnose lung cancer squamous cell carcinoma [<xref rid="B166-ijms-21-01193" ref-type="bibr">166</xref>]) [<xref rid="B143-ijms-21-01193" ref-type="bibr">143</xref>]. In addition to circulating miRNAs and lncRNAs, the existence of lung cancer CTCs can also predict a poor outcome for lung cancer patients. For example, the presence of CTCs at six months after surgery can increase the risk of metastasis and the short relapse-free survival of lung cancer patients [<xref rid="B167-ijms-21-01193" ref-type="bibr">167</xref>]. It has been shown that molecular characterizations (proteins, RNAs, etc.) are closely related to lung cancer detection, prognosis, and therapeutic efficacy [<xref rid="B168-ijms-21-01193" ref-type="bibr">168</xref>]. Therefore, miRNA, as a type of molecular characterization, might provide new ideas for the diagnosis of lung cancer metastasis, prognostic prediction, and therapeutic selection in lung cancer patients.</p>
      <p>Due to the multiple functions of miRNAs and lncRNAs in lung cancer metastasis, these RNAs have been regarded as promising therapeutic targets. Several traditional treatments have been discovered to target miRNAs and lncRNAs. Low-dose radiation can increase miR-30a and miR-30b expression. MiR-30a and miR-30b can inhibit plasminogen activator inhibitor-1 (PAI-1) expression and then reduce EMT and migration in NCI-H460 cells exposed to high-dose radiation. Additionally, miR-30a and miR-30b also promoted sensitivity to radiotherapy in a mouse model [<xref rid="B169-ijms-21-01193" ref-type="bibr">169</xref>]. In Lewis lung cancer cells, radiation can attenuate HOTAIR expression to reduce the nuclear localization of &#x3B2;-catenin, thereby inhibiting tumor cell proliferation [<xref rid="B170-ijms-21-01193" ref-type="bibr">170</xref>]. The effective chemotherapeutic drug, paclitaxel (PTX), can increase MEG3, thus promoting A549 cell apoptosis by increasing p53 expression. Further, over-expressed MEG3 can strengthen PTX&#x2019;s anti-tumor activity in A549 cells [<xref rid="B171-ijms-21-01193" ref-type="bibr">171</xref>]. DDP can increase miR-425-3p in cells and NSCLC cell-derived exosomes. Exosomal miR-425-3p can activate autophagy by inhibiting AKT1, ultimately repressing DDP sensitivity in A549 cells [<xref rid="B172-ijms-21-01193" ref-type="bibr">172</xref>]. MiRNAs can also exert therapeutic effects. MiR-200c can be delivered to lung tumor cells through nano vehicles. Nano miR-200c can increase the expressions of the tumor suppressors miR-29b and miR-1247 in metastatic and non-metastatic lung cancer cells. It can also suppress lung tumor cell migration and invasion [<xref rid="B173-ijms-21-01193" ref-type="bibr">173</xref>]. Tumor-derived exosomes can selectively deliver anticancer therapies to lung cancer sites due to their intrinsic organotropic tumor-homing properties [<xref rid="B174-ijms-21-01193" ref-type="bibr">174</xref>,<xref rid="B175-ijms-21-01193" ref-type="bibr">175</xref>,<xref rid="B176-ijms-21-01193" ref-type="bibr">176</xref>]. Functionalization of exosome-mimetic nanosystems (EMNs) with ITG&#x3B1;6&#x3B2;4 (F-EMNs) have similar structures and capabilities against tumor-derived exosomes and can escape endolysosomal degradation. MiR-145 can repress N-cadherin expression and then inhibit A549 cell migration and invasion [<xref rid="B177-ijms-21-01193" ref-type="bibr">177</xref>]. The injection of F-EMNs loaded with therapeutic oligonucleotide miR-145 can effectively reach lung tumor sites. Despite the nonnegligible safety concerns caused by their low systemic toxicities, this method remains a promising approach to target lung cancer cells during the targeted therapy process [<xref rid="B178-ijms-21-01193" ref-type="bibr">178</xref>]. It has been indicated that nanomedicine inhalation can also be used to treat lung cancer [<xref rid="B179-ijms-21-01193" ref-type="bibr">179</xref>]. One study found that siRNA combined with PTX inhalation via nanostructured lipid carriers can significantly decrease lung tumor volumes [<xref rid="B180-ijms-21-01193" ref-type="bibr">180</xref>]. Copper oxide nanoparticles can deliver miR-29b to A549 cells [<xref rid="B181-ijms-21-01193" ref-type="bibr">181</xref>], and this may inhibit lung tumor cells&#x2019; migration, invasion, and metastasis [<xref rid="B182-ijms-21-01193" ref-type="bibr">182</xref>]. Taken together, nano-miRNA inhalation might be a new strategy to deal with lung cancer metastasis, with few potential off-target effects and systemic toxicities [<xref rid="B183-ijms-21-01193" ref-type="bibr">183</xref>].</p>
      <p>Presently, despite the great progress that has been made in traditional lung cancer treatments, there are still multifaceted limitations impairing these treatments&#x2019; effects, such as therapeutic resistance and drug toxicity. As mentioned above, miRNAs and lncRNAs are widely involved in TGF-&#x3B2; signaling-regulated lung cancer metastasis. Targeting the miRNA/lncRNA-TGF-&#x3B2; signaling axis might provide new insights to decrease lung cancer metastasis and improve the prognosis of lung cancer patients. However, these studies are performed mostly on NSCLC cell lines, and studies on SCLC cell lines and in lung cancer tissues are still lacking. Therefore, further explorations in these microenvironments are required to elucidate the roles of miRNAs and lncRNAs in lung cancer more completely.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We would like to thank the technical support by Xian-Ling Qian and Lei Zhang.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>All authors (X.-N.L., J.L., L.-B.T., W.-T.C., L.Z., and L.-X.X.) contributed to the study conception and design. All authors have read and agreed to the published version of the manuscript.</p>
    </notes>
    <notes>
      <title>Funding</title>
      <p>This research was funded by the National Natural Science Foundation of China (No.31860317), the Undergraduates Training Programs of Innovation and Entrepreneurship of Nanchang University (No. 201801077).</p>
    </notes>
    <notes notes-type="COI-statement">
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <glossary>
      <title>Abbreviations</title>
      <array orientation="portrait">
        <tbody>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">ADAM12</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">a disintegrin and metalloprotease 12</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">AKT</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">protein kinase B</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">ATB</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">activated by TGF-&#x3B2;</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">CCNE2</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">cyclin E2</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">ceRNA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">competing endogenous RNA</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">circRNA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">circular RNA</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">Cox-2</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">cyclooxygenase-2</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">cPP1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">catalytic subunit of protein phosphatase 1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">CSC</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">cancer stem cell</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">CTC</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">circulating tumor cell</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">DAC</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">Decitabine</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">DAP12</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">DNAX activating protein 12 kDa</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">DDP</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">cisplatin</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">DOCK4</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">dedicator of cytokinesis 4</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">EC</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">endothelial cell</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">ECM</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">extracellular matrix</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">EED</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">embryonic ectoderm development</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">EMNs</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">exosome-mimetic nanosystems</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">EMT</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">epithelial-mesenchymal transition</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">ERK</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">extracellular signal-regulated kinase</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">EZH2</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">enhancer of zeste homologue 2</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">F-EMNs</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">Functionalization of EMNs with ITG&#x3B1;6&#x3B2;4</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">FOXM1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">forkhead Box M1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">FOXQ1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">forkhead box Q1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">HCP5</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">histocompatibility leukocyte antigen complex P5</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">HDAC4</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">histone deacetylase 4</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">HGAL</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">human germinal center-associated lymphoma</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">IL-10</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">interleukin-10</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">JAB1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">c-Jun activation domain-binding protein 1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">JAK</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">Janus-activated kinase</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">LATS2</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">large tumor suppressor homology 2 </td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">LEC</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">lymphatic endothelial cell</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">LINP1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">lncRNA in nonhomologous end joining (NHEJ) pathway 1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">LMO7</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">LIM-domain only protein 7 </td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">lncRNA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">long non-coding RNA</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MAGI2</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MALAT1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">metastasis-associated lung adenocarcinoma transcript 1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MAPK</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">mitogen-activated protein kinase</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MICA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">major histocompatibility complex class I chain-related A</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">miRNA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">microRNA</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">mRNA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">messenger RNA</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MMP</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">matrix metalloprotease</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MRE</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">miRNA response element</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MTDH</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">metadherin</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MT1-MMP</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">membrane type 1 MMP</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">MYEOV</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">myeloma overexpressed gene</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">nc-RNA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">non-coding RNA</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">NEDD4L</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">neural precursor cell expressed developmentally downregulated gene 4-like</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">NF-&#x3BA;B</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">nuclear factor-kappa B</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">NK</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">natural killer</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">NKILA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">NF-&#x3BA;B Interacting LncRNA</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">NSCLC</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">non-small cell lung cancer</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PAI-1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">plasminogen activator inhibitor-1 </td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PD-1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">programmed cell death protein-1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PD-L1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">programmed cell death ligand-1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">pFAK</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">phosphorylated focal adhesion kinase</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PGE2</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">prostaglandin E2</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PI3K</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">phosphatidylinositol-3-kinase</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PITX1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">paired-like homeodomain 1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PRC2</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">polycomb repressive complex 2</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PRKD3</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">protein kinase D 3</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">PTX</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">paclitaxel</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">qRT-PCR</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">quantitative real-time polymerase chain reaction</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">ROBO1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">roundabout, axon guidance receptor, and homolog 1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">SCLC</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">small cell lung cancer</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">SMURF</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">Smad ubiquitin regulatory factor</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">SOX4</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">sex-determining region Y-box 4</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">SOX7</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">SRY-Box 7</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">Sp1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">specificity protein 1</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">STAT3</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">signal transducer and activator of transcription 3</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">SULF2</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">sulfatase 2</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">TBILA</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">TGF-&#x3B2;-induced lncRNA</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">TCF4</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">transcription factor 4</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">TGF-&#x3B2;</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">transforming growth factor-&#x3B2;</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">TGFBR </td>
            <td align="left" valign="middle" rowspan="1" colspan="1">TGF-&#x3B2; receptor</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">TIF1&#x3B3;</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">transcriptional intermediary factor 1 &#x3B3;</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">Tregs</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">regulatory T cells</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">USP15</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">Ubiquitin specific protease 15</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">UTR</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">untranslated region</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">XIST</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">X inactivate-specific transcript</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">YAP</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">yes-associated protein</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">ZEB</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">Zinc finger E-box-binding homeobox</td>
          </tr>
          <tr>
            <td align="left" valign="middle" rowspan="1" colspan="1">Zo-1</td>
            <td align="left" valign="middle" rowspan="1" colspan="1">zonula occludens-1</td>
          </tr>
        </tbody>
      </array>
    </glossary>
    <ref-list>
      <title>References</title>
      <ref id="B1-ijms-21-01193">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siegel</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Jemal</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Cancer statistics, 2018</article-title>
          <source>CA Cancer J. Clin.</source>
          <year>2018</year>
          <volume>68</volume>
          <fpage>7</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.3322/caac.21442</pub-id>
          <pub-id pub-id-type="pmid">29313949</pub-id>
        </element-citation>
      </ref>
      <ref id="B2-ijms-21-01193">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bray</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ferlay</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Soerjomataram</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Torre</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Jemal</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>
          <source>CA A Cancer J. Clin.</source>
          <year>2018</year>
          <volume>68</volume>
          <fpage>394</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="doi">10.3322/caac.21492</pub-id>
          <pub-id pub-id-type="pmid">30207593</pub-id>
        </element-citation>
      </ref>
      <ref id="B3-ijms-21-01193">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bender</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology: The dominant malignancy</article-title>
          <source>Nature</source>
          <year>2014</year>
          <volume>513</volume>
          <fpage>S2</fpage>
          <pub-id pub-id-type="doi">10.1038/513S2a</pub-id>
          <pub-id pub-id-type="pmid">25208070</pub-id>
        </element-citation>
      </ref>
      <ref id="B4-ijms-21-01193">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Politi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Herbst</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>Lung cancer in the era of precision medicine</article-title>
          <source>Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.</source>
          <year>2015</year>
          <volume>21</volume>
          <fpage>2213</fpage>
          <lpage>2220</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-14-2748</pub-id>
          <pub-id pub-id-type="pmid">25979927</pub-id>
        </element-citation>
      </ref>
      <ref id="B5-ijms-21-01193">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Lien</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>The Roles of MicroRNA in Lung Cancer</article-title>
          <source>Int. J. Mol. Sci.</source>
          <year>2019</year>
          <volume>20</volume>
          <elocation-id>1611</elocation-id>
          <pub-id pub-id-type="doi">10.3390/ijms20071611</pub-id>
          <pub-id pub-id-type="pmid">30935143</pub-id>
        </element-citation>
      </ref>
      <ref id="B6-ijms-21-01193">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riihimaki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hemminki</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fallah</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Thomsen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sundquist</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sundquist</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hemminki</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Metastatic sites and survival in lung cancer</article-title>
          <source>Lung Cancer (Amst. Neth.)</source>
          <year>2014</year>
          <volume>86</volume>
          <fpage>78</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lungcan.2014.07.020</pub-id>
          <pub-id pub-id-type="pmid">25130083</pub-id>
        </element-citation>
      </ref>
      <ref id="B7-ijms-21-01193">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgensztern</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Govindan</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Trends in stage distribution for patients with non-small cell lung cancer: A National Cancer Database survey</article-title>
          <source>J. Thorac. Oncol.</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>29</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1097/JTO.0b013e3181c5920c</pub-id>
          <pub-id pub-id-type="pmid">19952801</pub-id>
        </element-citation>
      </ref>
      <ref id="B8-ijms-21-01193">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ettinger</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Aisner</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Akerley</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Bauman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chirieac</surname>
              <given-names>L.R.</given-names>
            </name>
            <name>
              <surname>D&#x2019;Amico</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>DeCamp</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Dilling</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Dobelbower</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology</article-title>
          <source>J. Natl. Compr. Canc. Netw.</source>
          <year>2017</year>
          <volume>15</volume>
          <fpage>504</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="doi">10.6004/jnccn.2017.0050</pub-id>
          <pub-id pub-id-type="pmid">28404761</pub-id>
        </element-citation>
      </ref>
      <ref id="B9-ijms-21-01193">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ettinger</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Akerley</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Bazhenova</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Borghaei</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Camidge</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Cheney</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Chirieac</surname>
              <given-names>L.R.</given-names>
            </name>
            <name>
              <surname>D&#x2019;Amico</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Dilling</surname>
              <given-names>T.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016</article-title>
          <source>J. Natl. Compr. Canc. Netw.</source>
          <year>2016</year>
          <volume>14</volume>
          <fpage>255</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="doi">10.6004/jnccn.2016.0031</pub-id>
          <pub-id pub-id-type="pmid">26957612</pub-id>
        </element-citation>
      </ref>
      <ref id="B10-ijms-21-01193">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicole</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Cappello</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Cappellesso</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>VandenBussche</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Fassina</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA profiling in serous cavity specimens: Diagnostic challenges and new opportunities</article-title>
          <source>Cancer Cytopathol.</source>
          <year>2019</year>
          <volume>127</volume>
          <fpage>493</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="doi">10.1002/cncy.22143</pub-id>
          <pub-id pub-id-type="pmid">31154675</pub-id>
        </element-citation>
      </ref>
      <ref id="B11-ijms-21-01193">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dykes</surname>
              <given-names>I.M.</given-names>
            </name>
            <name>
              <surname>Emanueli</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA</article-title>
          <source>Genom. Proteom. Bioinform.</source>
          <year>2017</year>
          <volume>15</volume>
          <fpage>177</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gpb.2016.12.005</pub-id>
          <pub-id pub-id-type="pmid">28529100</pub-id>
        </element-citation>
      </ref>
      <ref id="B12-ijms-21-01193">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krol</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Loedige</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Filipowicz</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>The widespread regulation of microRNA biogenesis, function and decay</article-title>
          <source>Nat. Rev. Genet.</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>597</fpage>
          <lpage>610</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg2843</pub-id>
          <pub-id pub-id-type="pmid">20661255</pub-id>
        </element-citation>
      </ref>
      <ref id="B13-ijms-21-01193">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shi</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNAs: A new frontier in the study of human diseases</article-title>
          <source>Cancer Lett.</source>
          <year>2013</year>
          <volume>339</volume>
          <fpage>159</fpage>
          <lpage>166</lpage>
          <pub-id pub-id-type="doi">10.1016/j.canlet.2013.06.013</pub-id>
          <pub-id pub-id-type="pmid">23791884</pub-id>
        </element-citation>
      </ref>
      <ref id="B14-ijms-21-01193">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Dutta</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNAs in cancer</article-title>
          <source>Annu. Rev. Pathol.</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>199</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.pathol.4.110807.092222</pub-id>
          <pub-id pub-id-type="pmid">18817506</pub-id>
        </element-citation>
      </ref>
      <ref id="B15-ijms-21-01193">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer</article-title>
          <source>J. Cancer Res. Clin. Oncol.</source>
          <year>2019</year>
          <volume>145</volume>
          <fpage>31</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="doi">10.1007/s00432-018-2767-5</pub-id>
          <pub-id pub-id-type="pmid">30417217</pub-id>
        </element-citation>
      </ref>
      <ref id="B16-ijms-21-01193">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>Q.</given-names>
            </name>
          </person-group>
          <article-title>Predictive relevance of ncRNAs in non-small-cell lung cancer patients with radiotherapy: A review of the published data</article-title>
          <source>Biomark. Med.</source>
          <year>2018</year>
          <volume>12</volume>
          <fpage>1149</fpage>
          <lpage>1159</lpage>
          <pub-id pub-id-type="doi">10.2217/bmm-2018-0004</pub-id>
          <pub-id pub-id-type="pmid">30191721</pub-id>
        </element-citation>
      </ref>
      <ref id="B17-ijms-21-01193">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>W.Q.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.Z.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-beta/SMAD signaling pathway</article-title>
          <source>Cell Cycle (Georget. Tex.)</source>
          <year>2019</year>
          <volume>18</volume>
          <fpage>1727</fpage>
          <lpage>1744</lpage>
          <pub-id pub-id-type="doi">10.1080/15384101.2019.1632135</pub-id>
        </element-citation>
      </ref>
      <ref id="B18-ijms-21-01193">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawasaki</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Miwa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hokari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sakurai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ohmori</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Miyauchi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Miyazono</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Koinuma</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding RNA NORAD regulates transforming growth factor-beta signaling and epithelial-to-mesenchymal transition-like phenotype</article-title>
          <source>Cancer Sci.</source>
          <year>2018</year>
          <volume>109</volume>
          <fpage>2211</fpage>
          <lpage>2220</lpage>
          <pub-id pub-id-type="doi">10.1111/cas.13626</pub-id>
          <pub-id pub-id-type="pmid">29722104</pub-id>
        </element-citation>
      </ref>
      <ref id="B19-ijms-21-01193">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNA XIST promotes TGF-&#x3B2;-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer</article-title>
          <source>Cancer Lett.</source>
          <year>2018</year>
          <volume>418</volume>
          <pub-id pub-id-type="doi">10.1016/j.canlet.2018.01.036</pub-id>
        </element-citation>
      </ref>
      <ref id="B20-ijms-21-01193">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Jing</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-beta1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137</article-title>
          <source>Genet. Test. Mol. Biomark.</source>
          <year>2018</year>
          <volume>22</volume>
          <fpage>333</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="doi">10.1089/gtmb.2018.0026</pub-id>
        </element-citation>
      </ref>
      <ref id="B21-ijms-21-01193">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#xFC;nker</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Krieglstein</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis</article-title>
          <source>Eur. J. Biochem.</source>
          <year>2000</year>
          <volume>267</volume>
          <fpage>6982</fpage>
          <lpage>6988</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01825.x</pub-id>
          <pub-id pub-id-type="pmid">11106407</pub-id>
        </element-citation>
      </ref>
      <ref id="B22-ijms-21-01193">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyazono</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Katsuno</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Koinuma</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ehata</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Morikawa</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Intracellular and extracellular TGF-beta signaling in cancer: Some recent topics</article-title>
          <source>Front. Med.</source>
          <year>2018</year>
          <volume>12</volume>
          <fpage>387</fpage>
          <lpage>411</lpage>
          <pub-id pub-id-type="doi">10.1007/s11684-018-0646-8</pub-id>
          <pub-id pub-id-type="pmid">30043220</pub-id>
        </element-citation>
      </ref>
      <ref id="B23-ijms-21-01193">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>D.-L.</given-names>
            </name>
            <name>
              <surname>Xiang</surname>
              <given-names>Y.-Y.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>L.-j.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>X.-J.</given-names>
            </name>
          </person-group>
          <article-title>Competing endogenous RNA interplay in cancer: Mechanism, methodology, and perspectives</article-title>
          <source>Tumor Biol.</source>
          <year>2015</year>
          <volume>36</volume>
          <fpage>479</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="doi">10.1007/s13277-015-3093-z</pub-id>
          <pub-id pub-id-type="pmid">25604144</pub-id>
        </element-citation>
      </ref>
      <ref id="B24-ijms-21-01193">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jonas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Izaurralde</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Towards a molecular understanding of microRNA-mediated gene silencing</article-title>
          <source>Nat. Rev. Genet.</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>421</fpage>
          <lpage>433</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg3965</pub-id>
          <pub-id pub-id-type="pmid">26077373</pub-id>
        </element-citation>
      </ref>
      <ref id="B25-ijms-21-01193">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Croce</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>Causes and consequences of microRNA dysregulation in cancer</article-title>
          <source>Nat. Rev. Genet.</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>704</fpage>
          <lpage>714</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg2634</pub-id>
          <pub-id pub-id-type="pmid">19763153</pub-id>
        </element-citation>
      </ref>
      <ref id="B26-ijms-21-01193">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stahlhut</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Slack</surname>
              <given-names>F.J.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNAs and the cancer phenotype: Profiling, signatures and clinical implications</article-title>
          <source>Genome Med.</source>
          <year>2013</year>
          <volume>5</volume>
          <fpage>111</fpage>
          <pub-id pub-id-type="doi">10.1186/gm516</pub-id>
          <pub-id pub-id-type="pmid">24373327</pub-id>
        </element-citation>
      </ref>
      <ref id="B27-ijms-21-01193">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNAs associated with therapy of non-small cell lung cancer</article-title>
          <source>Int. J. Biol. Sci.</source>
          <year>2018</year>
          <volume>14</volume>
          <fpage>390</fpage>
          <lpage>397</lpage>
          <pub-id pub-id-type="doi">10.7150/ijbs.22243</pub-id>
          <pub-id pub-id-type="pmid">29725260</pub-id>
        </element-citation>
      </ref>
      <ref id="B28-ijms-21-01193">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC)</article-title>
          <source>J. Thorac. Dis.</source>
          <year>2018</year>
          <volume>10</volume>
          <fpage>3119</fpage>
          <lpage>3131</lpage>
          <pub-id pub-id-type="doi">10.21037/jtd.2018.05.32</pub-id>
          <pub-id pub-id-type="pmid">29997981</pub-id>
        </element-citation>
      </ref>
      <ref id="B29-ijms-21-01193">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Osielska</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Jagodzinski</surname>
              <given-names>P.P.</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?</article-title>
          <source>Biomed. Pharmacother. Biomed. Pharmacother.</source>
          <year>2018</year>
          <volume>101</volume>
          <fpage>322</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biopha.2018.02.099</pub-id>
          <pub-id pub-id-type="pmid">29499406</pub-id>
        </element-citation>
      </ref>
      <ref id="B30-ijms-21-01193">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNA functions in lung cancer</article-title>
          <source>Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med.</source>
          <year>2015</year>
          <volume>36</volume>
          <fpage>4027</fpage>
          <lpage>4037</lpage>
          <pub-id pub-id-type="doi">10.1007/s13277-015-3449-4</pub-id>
        </element-citation>
      </ref>
      <ref id="B31-ijms-21-01193">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Humburg</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bendi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Callen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Buch</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis</article-title>
          <source>Oncotarget</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>18648</fpage>
          <lpage>18663</lpage>
          <pub-id pub-id-type="doi">10.18632/oncotarget.24307</pub-id>
          <pub-id pub-id-type="pmid">29719633</pub-id>
        </element-citation>
      </ref>
      <ref id="B32-ijms-21-01193">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding and circular RNAs in lung cancer: Advances and perspectives</article-title>
          <source>Epigenomics</source>
          <year>2016</year>
          <volume>8</volume>
          <fpage>1275</fpage>
          <lpage>1287</lpage>
          <pub-id pub-id-type="doi">10.2217/epi-2016-0036</pub-id>
          <pub-id pub-id-type="pmid">27585562</pub-id>
        </element-citation>
      </ref>
      <ref id="B33-ijms-21-01193">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Zhai</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Role of long non-coding RNA in drug resistance in non-small cell lung cancer</article-title>
          <source>Thorac. Cancer</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>761</fpage>
          <lpage>768</lpage>
          <pub-id pub-id-type="doi">10.1111/1759-7714.12652</pub-id>
          <pub-id pub-id-type="pmid">29726094</pub-id>
        </element-citation>
      </ref>
      <ref id="B34-ijms-21-01193">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ikushima</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Miyazono</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>TGFbeta signalling: A complex web in cancer progression</article-title>
          <source>Nat. Rev. Cancer</source>
          <year>2010</year>
          <volume>10</volume>
          <fpage>415</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc2853</pub-id>
          <pub-id pub-id-type="pmid">20495575</pub-id>
        </element-citation>
      </ref>
      <ref id="B35-ijms-21-01193">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tania</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer</article-title>
          <source>Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med.</source>
          <year>2014</year>
          <volume>35</volume>
          <fpage>7335</fpage>
          <lpage>7342</lpage>
          <pub-id pub-id-type="doi">10.1007/s13277-014-2163-y</pub-id>
        </element-citation>
      </ref>
      <ref id="B36-ijms-21-01193">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pardali</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Moustakas</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2007</year>
          <volume>1775</volume>
          <fpage>21</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbcan.2006.06.004</pub-id>
          <pub-id pub-id-type="pmid">16904831</pub-id>
        </element-citation>
      </ref>
      <ref id="B37-ijms-21-01193">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Pei</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Osthole inhibited TGF beta-induced epithelial-mesenchymal transition (EMT) by suppressing NF-kappaB mediated Snail activation in lung cancer A549 cells</article-title>
          <source>Cell Adhes. Migr.</source>
          <year>2017</year>
          <volume>11</volume>
          <fpage>464</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="doi">10.1080/19336918.2016.1259058</pub-id>
        </element-citation>
      </ref>
      <ref id="B38-ijms-21-01193">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>R.-Y.</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.-T.</given-names>
            </name>
          </person-group>
          <article-title>JAK/STAT3 signaling is required for TGF-&#x3B2;-induced epithelial-mesenchymal transition in lung cancer cells</article-title>
          <source>Int. J. Oncol.</source>
          <year>2014</year>
          <volume>44</volume>
          <fpage>1643</fpage>
          <lpage>1651</lpage>
          <pub-id pub-id-type="doi">10.3892/ijo.2014.2310</pub-id>
          <pub-id pub-id-type="pmid">24573038</pub-id>
        </element-citation>
      </ref>
      <ref id="B39-ijms-21-01193">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>X.F.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H.B.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>W.Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways</article-title>
          <source>Mol. Biol. Rep.</source>
          <year>2012</year>
          <volume>39</volume>
          <fpage>3549</fpage>
          <lpage>3556</lpage>
          <pub-id pub-id-type="doi">10.1007/s11033-011-1128-0</pub-id>
          <pub-id pub-id-type="pmid">21713404</pub-id>
        </element-citation>
      </ref>
      <ref id="B40-ijms-21-01193">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis</article-title>
          <source>Dev. Cell</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>818</fpage>
          <lpage>829</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2008.05.009</pub-id>
          <pub-id pub-id-type="pmid">18539112</pub-id>
        </element-citation>
      </ref>
      <ref id="B41-ijms-21-01193">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gunaratne</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Di Guglielmo</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>Par6 is phosphorylated by aPKC to facilitate EMT</article-title>
          <source>Cell Adhes. Migr.</source>
          <year>2013</year>
          <volume>7</volume>
          <fpage>357</fpage>
          <lpage>361</lpage>
          <pub-id pub-id-type="doi">10.4161/cam.25651</pub-id>
          <pub-id pub-id-type="pmid">23880940</pub-id>
        </element-citation>
      </ref>
      <ref id="B42-ijms-21-01193">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fong</surname>
              <given-names>Y.C.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Kao</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>C.H.</given-names>
            </name>
          </person-group>
          <article-title>Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells</article-title>
          <source>Lung Cancer (Amst. Neth.)</source>
          <year>2009</year>
          <volume>64</volume>
          <fpage>13</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lungcan.2008.07.010</pub-id>
          <pub-id pub-id-type="pmid">18771813</pub-id>
        </element-citation>
      </ref>
      <ref id="B43-ijms-21-01193">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mise</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Savai</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kaminski</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Eickelberg</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Zyxin is a transforming growth factor-beta (TGF-beta)/Smad3 target gene that regulates lung cancer cell motility via integrin alpha5beta1</article-title>
          <source>J. Biol. Chem.</source>
          <year>2012</year>
          <volume>287</volume>
          <fpage>31393</fpage>
          <lpage>31405</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M112.357624</pub-id>
          <pub-id pub-id-type="pmid">22778267</pub-id>
        </element-citation>
      </ref>
      <ref id="B44-ijms-21-01193">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parekh</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of invadopodia by mechanical signaling</article-title>
          <source>Exp. Cell Res.</source>
          <year>2016</year>
          <volume>343</volume>
          <fpage>89</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yexcr.2015.10.038</pub-id>
          <pub-id pub-id-type="pmid">26546985</pub-id>
        </element-citation>
      </ref>
      <ref id="B45-ijms-21-01193">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eddy</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Weidmann</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Condeelis</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis</article-title>
          <source>Trends Cell Biol.</source>
          <year>2017</year>
          <volume>27</volume>
          <fpage>595</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tcb.2017.03.003</pub-id>
          <pub-id pub-id-type="pmid">28412099</pub-id>
        </element-citation>
      </ref>
      <ref id="B46-ijms-21-01193">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pelaez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Morales</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Salvo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Garasa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ortiz de Solorzano</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Larrayoz</surname>
              <given-names>I.M.</given-names>
            </name>
            <name>
              <surname>Rouzaut</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>beta3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells</article-title>
          <source>PLoS ONE</source>
          <year>2017</year>
          <volume>12</volume>
          <elocation-id>e0181579</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0181579</pub-id>
          <pub-id pub-id-type="pmid">28767724</pub-id>
        </element-citation>
      </ref>
      <ref id="B47-ijms-21-01193">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reymond</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>d&#x2019;Agua</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Ridley</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Crossing the endothelial barrier during metastasis</article-title>
          <source>Nat. Rev. Cancer</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>858</fpage>
          <lpage>870</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc3628</pub-id>
          <pub-id pub-id-type="pmid">24263189</pub-id>
        </element-citation>
      </ref>
      <ref id="B48-ijms-21-01193">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salvo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Garasa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dotor</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Morales</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Pelaez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Altevogt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Rouzaut</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Combined targeting of TGF-&#x3B2;1 and integrin &#x3B2;3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer</article-title>
          <source>Mol. Cancer</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>112</fpage>
          <pub-id pub-id-type="doi">10.1186/1476-4598-13-112</pub-id>
          <pub-id pub-id-type="pmid">24884715</pub-id>
        </element-citation>
      </ref>
      <ref id="B49-ijms-21-01193">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baratelli</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Hazra</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Walser</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Schaue</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pak</surname>
              <given-names>P.S.</given-names>
            </name>
            <name>
              <surname>Elashoff</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Reckamp</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer</article-title>
          <source>Am. J. Transl. Res.</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>356</fpage>
          <lpage>367</lpage>
          <pub-id pub-id-type="pmid">20733946</pub-id>
        </element-citation>
      </ref>
      <ref id="B50-ijms-21-01193">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>David</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Dominguez</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>McCampbell</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>Gulley</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Schlom</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Palena</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>A novel bifunctional anti-PD-L1/TGF-beta Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells</article-title>
          <source>Oncoimmunology</source>
          <year>2017</year>
          <volume>6</volume>
          <fpage>e1349589</fpage>
          <pub-id pub-id-type="doi">10.1080/2162402X.2017.1349589</pub-id>
          <pub-id pub-id-type="pmid">29123964</pub-id>
        </element-citation>
      </ref>
      <ref id="B51-ijms-21-01193">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santarpia</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gonzalez-Cao</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Viteri</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Karachaliou</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Altavilla</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rosell</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: Understanding transforming growth factor-beta role</article-title>
          <source>Transl. Lung Cancer Res.</source>
          <year>2015</year>
          <volume>4</volume>
          <fpage>728</fpage>
          <lpage>742</lpage>
          <pub-id pub-id-type="doi">10.3978/j.issn.2218-6751.2015.12.04</pub-id>
          <pub-id pub-id-type="pmid">26798582</pub-id>
        </element-citation>
      </ref>
      <ref id="B52-ijms-21-01193">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trinh</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Kandell</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Donatelli</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Tejera</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Gilvary</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Eksioglu</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Burnette</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>W.A.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immune evasion by TGFbeta-induced miR-183 repression of MICA/B expression in human lung tumor cells</article-title>
          <source>Oncoimmunology</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>e1557372</fpage>
          <pub-id pub-id-type="doi">10.1080/2162402X.2018.1557372</pub-id>
          <pub-id pub-id-type="pmid">30906652</pub-id>
        </element-citation>
      </ref>
      <ref id="B53-ijms-21-01193">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miles</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Pruitt</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>van Golen</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>C.R.</given-names>
            </name>
          </person-group>
          <article-title>Stepping out of the flow: Capillary extravasation in cancer metastasis</article-title>
          <source>Clin. Exp. Metastasis</source>
          <year>2008</year>
          <volume>25</volume>
          <fpage>305</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="doi">10.1007/s10585-007-9098-2</pub-id>
          <pub-id pub-id-type="pmid">17906932</pub-id>
        </element-citation>
      </ref>
      <ref id="B54-ijms-21-01193">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Tai</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hammell</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Wilkinson</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Roe</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Vakoc</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Van Aelst</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>TGF-beta/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis</article-title>
          <source>Genes Dev.</source>
          <year>2015</year>
          <volume>29</volume>
          <fpage>250</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.248963.114</pub-id>
          <pub-id pub-id-type="pmid">25644601</pub-id>
        </element-citation>
      </ref>
      <ref id="B55-ijms-21-01193">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popper</surname>
              <given-names>H.H.</given-names>
            </name>
          </person-group>
          <article-title>Progression and metastasis of lung cancer</article-title>
          <source>Cancer Metastasis Rev.</source>
          <year>2016</year>
          <volume>35</volume>
          <fpage>75</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1007/s10555-016-9618-0</pub-id>
          <pub-id pub-id-type="pmid">27018053</pub-id>
        </element-citation>
      </ref>
      <ref id="B56-ijms-21-01193">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vicent</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Luis-Ravelo</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Anton</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Garcia-Tunon</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Borras-Cuesta</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Dotor</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>De Las Rivas</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lecanda</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism</article-title>
          <source>Cancer Res.</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>2275</fpage>
          <lpage>2285</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-6493</pub-id>
          <pub-id pub-id-type="pmid">18381434</pub-id>
        </element-citation>
      </ref>
      <ref id="B57-ijms-21-01193">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luis-Ravelo</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Anton</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Zandueta</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Valencia</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ormazabal</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Martinez-Canarias</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Guruceaga</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Perurena</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Vicent</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>De Las Rivas</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer</article-title>
          <source>Oncogene</source>
          <year>2014</year>
          <volume>33</volume>
          <fpage>5090</fpage>
          <lpage>5099</lpage>
          <pub-id pub-id-type="doi">10.1038/onc.2013.440</pub-id>
          <pub-id pub-id-type="pmid">24166494</pub-id>
        </element-citation>
      </ref>
      <ref id="B58-ijms-21-01193">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer</article-title>
          <source>PLoS ONE</source>
          <year>2014</year>
          <volume>9</volume>
          <elocation-id>e87780</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0087780</pub-id>
          <pub-id pub-id-type="pmid">24523873</pub-id>
        </element-citation>
      </ref>
      <ref id="B59-ijms-21-01193">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qu</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Z.Q.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q.E.</given-names>
            </name>
          </person-group>
          <article-title>miR-93 promotes TGF-beta-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells</article-title>
          <source>Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med.</source>
          <year>2016</year>
          <volume>37</volume>
          <fpage>5645</fpage>
          <lpage>5651</lpage>
          <pub-id pub-id-type="doi">10.1007/s13277-015-4328-8</pub-id>
        </element-citation>
      </ref>
      <ref id="B60-ijms-21-01193">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Lv</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer</article-title>
          <source>PLoS ONE</source>
          <year>2012</year>
          <volume>7</volume>
          <elocation-id>e43268</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0043268</pub-id>
          <pub-id pub-id-type="pmid">22937028</pub-id>
        </element-citation>
      </ref>
      <ref id="B61-ijms-21-01193">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cai</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Simultaneous overactivation of Wnt/beta-catenin and TGFbeta signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC</article-title>
          <source>Nat. Commun.</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>15870</fpage>
          <pub-id pub-id-type="doi">10.1038/ncomms15870</pub-id>
          <pub-id pub-id-type="pmid">28627514</pub-id>
        </element-citation>
      </ref>
      <ref id="B62-ijms-21-01193">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.N.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.B.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>TGF-beta1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin</article-title>
          <source>Cell. Mol. Biol. Lett.</source>
          <year>2017</year>
          <volume>22</volume>
          <fpage>22</fpage>
          <pub-id pub-id-type="doi">10.1186/s11658-017-0053-1</pub-id>
          <pub-id pub-id-type="pmid">29118814</pub-id>
        </element-citation>
      </ref>
      <ref id="B63-ijms-21-01193">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>MiR-9 is involved in TGF-&#x3B2;1-induced lung cancer cell invasion and adhesion by targeting SOX7</article-title>
          <source>J. Cell. Mol. Med.</source>
          <year>2017</year>
          <volume>21</volume>
          <fpage>2000</fpage>
          <lpage>2008</lpage>
          <pub-id pub-id-type="doi">10.1111/jcmm.13120</pub-id>
          <pub-id pub-id-type="pmid">28266181</pub-id>
        </element-citation>
      </ref>
      <ref id="B64-ijms-21-01193">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shoji</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tsuchida</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kishi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yamakawa</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Matsuzaki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sugino</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of a PDZ protein that interacts with activin type II receptors</article-title>
          <source>J. Biol. Chem.</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>5485</fpage>
          <lpage>5492</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.275.8.5485</pub-id>
          <pub-id pub-id-type="pmid">10681527</pub-id>
        </element-citation>
      </ref>
      <ref id="B65-ijms-21-01193">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitamura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Seike</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Okano</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Miyanaga</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mizutani</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Noro</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Minegishi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gemma</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>MiR-134/487b/655 cluster regulates TGF-&#x3B2;-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells</article-title>
          <source>Mol. Cancer Ther.</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>444</fpage>
          <lpage>453</lpage>
          <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-13-0448</pub-id>
          <pub-id pub-id-type="pmid">24258346</pub-id>
        </element-citation>
      </ref>
      <ref id="B66-ijms-21-01193">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer</article-title>
          <source>Acta Biochim. Et Biophys. Sin.</source>
          <year>2015</year>
          <volume>47</volume>
          <fpage>431</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="doi">10.1093/abbs/gmv032</pub-id>
        </element-citation>
      </ref>
      <ref id="B67-ijms-21-01193">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>The key microRNAs regulated the development of non-small cell lung cancer by targeting TGF-beta-induced epithelial-mesenchymal transition</article-title>
          <source>Comb. Chem. High Throughput Screen.</source>
          <year>2019</year>
          <pub-id pub-id-type="doi">10.2174/1386207322666190410151945</pub-id>
        </element-citation>
      </ref>
      <ref id="B68-ijms-21-01193">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3betaMediated Wnt/beta-Catenin Pathway</article-title>
          <source>Cancer Res. Treat.</source>
          <year>2019</year>
          <pub-id pub-id-type="doi">10.4143/crt.2018.638</pub-id>
        </element-citation>
      </ref>
      <ref id="B69-ijms-21-01193">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hutter</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Sheikh</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Holbrook</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Transforming growth factor-beta 1 suppresses serum deprivation-induced death of A549 cells through differential effects on c-Jun and JNK activities</article-title>
          <source>J. Biol. Chem.</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>18234</fpage>
          <lpage>18242</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M909431199</pub-id>
          <pub-id pub-id-type="pmid">10748131</pub-id>
        </element-citation>
      </ref>
      <ref id="B70-ijms-21-01193">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pirozzi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Tirino</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Camerlingo</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>La Rocca</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Liguori</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Martucci</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Paino</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Normanno</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Rocco</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Epithelial to mesenchymal transition by TGF&#x3B2;-1 induction increases stemness characteristics in primary non small cell lung cancer cell line</article-title>
          <source>PLoS ONE</source>
          <year>2011</year>
          <volume>6</volume>
          <elocation-id>e21548</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0021548</pub-id>
          <pub-id pub-id-type="pmid">21738704</pub-id>
        </element-citation>
      </ref>
      <ref id="B71-ijms-21-01193">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2</article-title>
          <source>Biomed. Pharmacother. Biomed. Pharmacother.</source>
          <year>2017</year>
          <volume>96</volume>
          <fpage>1170</fpage>
          <lpage>1178</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biopha.2017.11.105</pub-id>
          <pub-id pub-id-type="pmid">29239816</pub-id>
        </element-citation>
      </ref>
      <ref id="B72-ijms-21-01193">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leon</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>MacDonagh</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Finn</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Cuffe</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Barr</surname>
              <given-names>M.P.</given-names>
            </name>
          </person-group>
          <article-title>Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways</article-title>
          <source>Pharmacol. Ther.</source>
          <year>2016</year>
          <volume>158</volume>
          <fpage>71</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.12.001</pub-id>
          <pub-id pub-id-type="pmid">26706243</pub-id>
        </element-citation>
      </ref>
      <ref id="B73-ijms-21-01193">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>miR181b5p mediates TGFbeta1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells</article-title>
          <source>Int. J. Oncol.</source>
          <year>2017</year>
          <volume>51</volume>
          <fpage>158</fpage>
          <lpage>168</lpage>
          <pub-id pub-id-type="doi">10.3892/ijo.2017.4007</pub-id>
          <pub-id pub-id-type="pmid">28534939</pub-id>
        </element-citation>
      </ref>
      <ref id="B74-ijms-21-01193">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Seike</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Soeno</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mizutani</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kitamura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Minegishi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Noro</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Gemma</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>MiR-23a regulates TGF-beta-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells</article-title>
          <source>Int. J. Oncol.</source>
          <year>2012</year>
          <volume>41</volume>
          <fpage>869</fpage>
          <lpage>875</lpage>
          <pub-id pub-id-type="doi">10.3892/ijo.2012.1535</pub-id>
          <pub-id pub-id-type="pmid">22752005</pub-id>
        </element-citation>
      </ref>
      <ref id="B75-ijms-21-01193">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soung</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Emerging roles of exosomes in cancer invasion and metastasis</article-title>
          <source>Bmb. Rep.</source>
          <year>2016</year>
          <volume>49</volume>
          <fpage>18</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.5483/BMBRep.2016.49.1.239</pub-id>
          <pub-id pub-id-type="pmid">26592936</pub-id>
        </element-citation>
      </ref>
      <ref id="B76-ijms-21-01193">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>T.Y.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Mun</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Ihm</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Exosome cargo reflects TGF-beta1-mediated epithelial-to-mesenchymal transition (EMT) status in A549 human lung adenocarcinoma cells</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2016</year>
          <volume>478</volume>
          <fpage>643</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.07.124</pub-id>
          <pub-id pub-id-type="pmid">27492069</pub-id>
        </element-citation>
      </ref>
      <ref id="B77-ijms-21-01193">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>J.X.</given-names>
            </name>
            <name>
              <surname>Zhai</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>X.T.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGF&#x3B2;1/Smad2 in human non-small cell lung cancer</article-title>
          <source>Eur. Rev. Med. Pharmacol. Sci.</source>
          <year>2016</year>
          <volume>20</volume>
          <fpage>3793</fpage>
          <lpage>3801</lpage>
          <pub-id pub-id-type="pmid">27735039</pub-id>
        </element-citation>
      </ref>
      <ref id="B78-ijms-21-01193">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.T.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>MiR-145 and miR-203 represses TGF-beta-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells</article-title>
          <source>Lung Cancer (Amst. Neth.)</source>
          <year>2016</year>
          <volume>97</volume>
          <fpage>87</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lungcan.2016.04.017</pub-id>
        </element-citation>
      </ref>
      <ref id="B79-ijms-21-01193">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Repression of Smad4 by miR205 moderates TGF-beta-induced epithelial-mesenchymal transition in A549 cell lines</article-title>
          <source>Int. J. Oncol.</source>
          <year>2016</year>
          <volume>49</volume>
          <fpage>700</fpage>
          <lpage>708</lpage>
          <pub-id pub-id-type="doi">10.3892/ijo.2016.3547</pub-id>
          <pub-id pub-id-type="pmid">27279345</pub-id>
        </element-citation>
      </ref>
      <ref id="B80-ijms-21-01193">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The feedback loop between miR-124 and TGF-&#x3B2; pathway plays a significant role in non-small cell lung cancer metastasis</article-title>
          <source>Carcinogenesis</source>
          <year>2016</year>
          <volume>37</volume>
          <fpage>333</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="doi">10.1093/carcin/bgw011</pub-id>
          <pub-id pub-id-type="pmid">26818357</pub-id>
        </element-citation>
      </ref>
      <ref id="B81-ijms-21-01193">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Circulating microRNA-422a is associated with lymphatic metastasis in lung cancer</article-title>
          <source>Oncotarget</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>42173</fpage>
          <lpage>42188</lpage>
          <pub-id pub-id-type="doi">10.18632/oncotarget.15025</pub-id>
          <pub-id pub-id-type="pmid">28178679</pub-id>
        </element-citation>
      </ref>
      <ref id="B82-ijms-21-01193">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bai</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Hua</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-196b Inhibits Cell Growth and Metastasis of Lung Cancer Cells by Targeting Runx2</article-title>
          <source>Cell. Physiol. Biochem.</source>
          <year>2017</year>
          <volume>43</volume>
          <fpage>757</fpage>
          <lpage>767</lpage>
          <pub-id pub-id-type="doi">10.1159/000481559</pub-id>
          <pub-id pub-id-type="pmid">28950255</pub-id>
        </element-citation>
      </ref>
      <ref id="B83-ijms-21-01193">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>MiR-940 inhibits TGF-beta-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer</article-title>
          <source>J. Cancer</source>
          <year>2019</year>
          <volume>10</volume>
          <fpage>2735</fpage>
          <lpage>2744</lpage>
          <pub-id pub-id-type="doi">10.7150/jca.31800</pub-id>
          <pub-id pub-id-type="pmid">31258781</pub-id>
        </element-citation>
      </ref>
      <ref id="B84-ijms-21-01193">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.M.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Z.F.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.H.</given-names>
            </name>
          </person-group>
          <article-title>MiR-22 inhibits lung cancer cell EMT and invasion through targeting Snail</article-title>
          <source>Eur. Rev. Med Pharmacol. Sci.</source>
          <year>2017</year>
          <volume>21</volume>
          <fpage>3598</fpage>
          <lpage>3604</lpage>
          <pub-id pub-id-type="pmid">28925484</pub-id>
        </element-citation>
      </ref>
      <ref id="B85-ijms-21-01193">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oktyabri</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Tange</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Terashima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ishimura</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-&#x3B2;</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2014</year>
          <volume>453</volume>
          <fpage>124</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2014.09.082</pub-id>
          <pub-id pub-id-type="pmid">25264103</pub-id>
        </element-citation>
      </ref>
      <ref id="B86-ijms-21-01193">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tange</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Oktyabri</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Terashima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ishimura</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>JARID2 is involved in transforming growth factor-&#x3B2;-induced epithelial-mesenchymal transition of lung and colon cancer cell lines</article-title>
          <source>PLoS ONE</source>
          <year>2014</year>
          <volume>9</volume>
          <elocation-id>e115684</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0115684</pub-id>
          <pub-id pub-id-type="pmid">25542019</pub-id>
        </element-citation>
      </ref>
      <ref id="B87-ijms-21-01193">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yin</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Shan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>miR-145 and miR-497 suppress TGF-&#x3B2;-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH</article-title>
          <source>Cancer Cell Int.</source>
          <year>2018</year>
          <volume>18</volume>
          <fpage>105</fpage>
          <pub-id pub-id-type="doi">10.1186/s12935-018-0601-4</pub-id>
          <pub-id pub-id-type="pmid">30065618</pub-id>
        </element-citation>
      </ref>
      <ref id="B88-ijms-21-01193">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ke</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1</article-title>
          <source>Biochem. Res. Int.</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>506731</fpage>
          <pub-id pub-id-type="doi">10.1155/2013/506731</pub-id>
          <pub-id pub-id-type="pmid">23762558</pub-id>
        </element-citation>
      </ref>
      <ref id="B89-ijms-21-01193">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Ying</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells</article-title>
          <source>Febs Lett.</source>
          <year>2012</year>
          <volume>586</volume>
          <fpage>3761</fpage>
          <lpage>3765</lpage>
          <pub-id pub-id-type="doi">10.1016/j.febslet.2012.09.016</pub-id>
          <pub-id pub-id-type="pmid">23010597</pub-id>
        </element-citation>
      </ref>
      <ref id="B90-ijms-21-01193">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1</article-title>
          <source>Arch. De Bronconeumol.</source>
          <year>2016</year>
          <volume>52</volume>
          <fpage>505</fpage>
          <lpage>511</lpage>
          <pub-id pub-id-type="doi">10.1016/j.arbres.2015.10.016</pub-id>
        </element-citation>
      </ref>
      <ref id="B91-ijms-21-01193">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.X.</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.Z.</given-names>
            </name>
            <name>
              <surname>Nian</surname>
              <given-names>W.Q.</given-names>
            </name>
          </person-group>
          <article-title>A regulatory loop involving miR-29c and Sp1 elevates the TGF-beta1 mediated epithelial-to-mesenchymal transition in lung cancer</article-title>
          <source>Oncotarget</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>85905</fpage>
          <lpage>85916</lpage>
          <pub-id pub-id-type="doi">10.18632/oncotarget.13137</pub-id>
          <pub-id pub-id-type="pmid">27829234</pub-id>
        </element-citation>
      </ref>
      <ref id="B92-ijms-21-01193">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yue</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Heintz</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>15077</fpage>
          <lpage>15082</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.2436255100</pub-id>
          <pub-id pub-id-type="pmid">14657337</pub-id>
        </element-citation>
      </ref>
      <ref id="B93-ijms-21-01193">
        <label>93.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bhagat</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Furuya</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hibshoosh</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Troxel</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Eskelinen</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ohsumi</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene</article-title>
          <source>J. Clin. Investig.</source>
          <year>2003</year>
          <volume>112</volume>
          <fpage>1809</fpage>
          <lpage>1820</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI20039</pub-id>
          <pub-id pub-id-type="pmid">14638851</pub-id>
        </element-citation>
      </ref>
      <ref id="B94-ijms-21-01193">
        <label>94.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.B.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>miR-16 mimics inhibit TGF-beta1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells</article-title>
          <source>Oncol. Rep.</source>
          <year>2018</year>
          <volume>39</volume>
          <fpage>247</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="doi">10.3892/or.2017.6088</pub-id>
          <pub-id pub-id-type="pmid">29138833</pub-id>
        </element-citation>
      </ref>
      <ref id="B95-ijms-21-01193">
        <label>95.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Targeting ZEB2 By microRNA-129 In Non-Small Cell Lung Cancer Suppresses Cell Proliferation, Invasion and Migration Via Regulating Wnt/&#x3B2;-Catenin Signaling Pathway and Epithelial-Mesenchymal Transition</article-title>
          <source>Oncotargets Ther.</source>
          <year>2019</year>
          <volume>12</volume>
          <fpage>9165</fpage>
          <lpage>9175</lpage>
          <pub-id pub-id-type="doi">10.2147/OTT.S217536</pub-id>
        </element-citation>
      </ref>
      <ref id="B96-ijms-21-01193">
        <label>96.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bin</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Xiaofeng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wanzi</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism</article-title>
          <source>Exp. Lung Res.</source>
          <year>2018</year>
          <volume>44</volume>
          <fpage>280</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="doi">10.1080/01902148.2018.1536174</pub-id>
          <pub-id pub-id-type="pmid">30475081</pub-id>
        </element-citation>
      </ref>
      <ref id="B97-ijms-21-01193">
        <label>97.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>Y.L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2</article-title>
          <source>Life Sci.</source>
          <year>2018</year>
          <volume>199</volume>
          <fpage>104</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lfs.2018.03.005</pub-id>
          <pub-id pub-id-type="pmid">29510198</pub-id>
        </element-citation>
      </ref>
      <ref id="B98-ijms-21-01193">
        <label>98.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/&#x3B2;-catenin signaling in non-small-cell lung cancer</article-title>
          <source>Mol. Carcinog.</source>
          <year>2018</year>
          <volume>57</volume>
          <fpage>842</fpage>
          <lpage>853</lpage>
          <pub-id pub-id-type="doi">10.1002/mc.22805</pub-id>
          <pub-id pub-id-type="pmid">29566281</pub-id>
        </element-citation>
      </ref>
      <ref id="B99-ijms-21-01193">
        <label>99.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2</article-title>
          <source>PLoS Genet.</source>
          <year>2018</year>
          <volume>14</volume>
          <elocation-id>e1007790</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1007790</pub-id>
          <pub-id pub-id-type="pmid">30557355</pub-id>
        </element-citation>
      </ref>
      <ref id="B100-ijms-21-01193">
        <label>100.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y.X.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>Y.F.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>J.X.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth</article-title>
          <source>Cell Death Dis.</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>e2528</fpage>
          <pub-id pub-id-type="doi">10.1038/cddis.2016.432</pub-id>
          <pub-id pub-id-type="pmid">28005074</pub-id>
        </element-citation>
      </ref>
      <ref id="B101-ijms-21-01193">
        <label>101.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Sempere</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Ouyang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Memoli</surname>
              <given-names>V.A.</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Demidenko</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Korc</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Preis</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors</article-title>
          <source>J. Clin. Investig.</source>
          <year>2010</year>
          <volume>120</volume>
          <fpage>1298</fpage>
          <lpage>1309</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI39566</pub-id>
          <pub-id pub-id-type="pmid">20237410</pub-id>
        </element-citation>
      </ref>
      <ref id="B102-ijms-21-01193">
        <label>102.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Targeting Smad2 and Smad3 by miR-136 suppresses metastasis-associated traits of lung adenocarcinoma cells</article-title>
          <source>Oncol. Res.</source>
          <year>2013</year>
          <volume>21</volume>
          <fpage>345</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="doi">10.3727/096504014X14024160459285</pub-id>
          <pub-id pub-id-type="pmid">25198664</pub-id>
        </element-citation>
      </ref>
      <ref id="B103-ijms-21-01193">
        <label>103.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Hsiao</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Kao</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.L.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>P.C.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma</article-title>
          <source>PLoS ONE</source>
          <year>2014</year>
          <volume>9</volume>
          <elocation-id>e96765</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0096765</pub-id>
          <pub-id pub-id-type="pmid">24816813</pub-id>
        </element-citation>
      </ref>
      <ref id="B104-ijms-21-01193">
        <label>104.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>An</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Transforming growth factor-&#x3B2;-induced miR143 expression in regulation of non-small cell lung cancer cell viability and invasion capacity in vitro and in vivo</article-title>
          <source>Int. J. Oncol.</source>
          <year>2014</year>
          <volume>45</volume>
          <fpage>1977</fpage>
          <lpage>1988</lpage>
          <pub-id pub-id-type="doi">10.3892/ijo.2014.2623</pub-id>
          <pub-id pub-id-type="pmid">25175415</pub-id>
        </element-citation>
      </ref>
      <ref id="B105-ijms-21-01193">
        <label>105.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer</article-title>
          <source>Cancer Res.</source>
          <year>2013</year>
          <volume>73</volume>
          <fpage>3326</fpage>
          <lpage>3335</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-3055</pub-id>
          <pub-id pub-id-type="pmid">23592755</pub-id>
        </element-citation>
      </ref>
      <ref id="B106-ijms-21-01193">
        <label>106.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>TGFbeta1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2018</year>
          <volume>496</volume>
          <fpage>1169</fpage>
          <lpage>1175</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.01.164</pub-id>
          <pub-id pub-id-type="pmid">29407170</pub-id>
        </element-citation>
      </ref>
      <ref id="B107-ijms-21-01193">
        <label>107.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ge</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>X.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis</article-title>
          <source>Theranostics</source>
          <year>2019</year>
          <volume>9</volume>
          <fpage>2460</fpage>
          <lpage>2474</lpage>
          <pub-id pub-id-type="doi">10.7150/thno.31097</pub-id>
          <pub-id pub-id-type="pmid">31131047</pub-id>
        </element-citation>
      </ref>
      <ref id="B108-ijms-21-01193">
        <label>108.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bian</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p</article-title>
          <source>Mol. Genet. Genom. Med.</source>
          <year>2019</year>
          <volume>7</volume>
          <fpage>e757</fpage>
          <pub-id pub-id-type="doi">10.1002/mgg3.757</pub-id>
        </element-citation>
      </ref>
      <ref id="B109-ijms-21-01193">
        <label>109.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p</article-title>
          <source>Mol. Cancer</source>
          <year>2017</year>
          <volume>16</volume>
          <fpage>118</fpage>
          <pub-id pub-id-type="doi">10.1186/s12943-017-0685-9</pub-id>
          <pub-id pub-id-type="pmid">28697764</pub-id>
        </element-citation>
      </ref>
      <ref id="B110-ijms-21-01193">
        <label>110.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terashima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tange</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ishimura</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines</article-title>
          <source>J. Biol. Chem.</source>
          <year>2017</year>
          <volume>292</volume>
          <fpage>82</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M116.750950</pub-id>
          <pub-id pub-id-type="pmid">27852821</pub-id>
        </element-citation>
      </ref>
      <ref id="B111-ijms-21-01193">
        <label>111.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terashima</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ishimura</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wanna-Udom</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells</article-title>
          <source>J. Biol. Chem.</source>
          <year>2018</year>
          <volume>293</volume>
          <fpage>18016</fpage>
          <lpage>18030</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.RA118.004006</pub-id>
          <pub-id pub-id-type="pmid">30262664</pub-id>
        </element-citation>
      </ref>
      <ref id="B112-ijms-21-01193">
        <label>112.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>LncRNA ATB promotes the proliferation and metastasis of lung cancer via activation of the p38 signaling pathway</article-title>
          <source>Oncol. Lett.</source>
          <year>2018</year>
          <volume>16</volume>
          <fpage>3907</fpage>
          <lpage>3912</lpage>
          <pub-id pub-id-type="doi">10.3892/ol.2018.9117</pub-id>
          <pub-id pub-id-type="pmid">30128006</pub-id>
        </element-citation>
      </ref>
      <ref id="B113-ijms-21-01193">
        <label>113.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>LncRNA ATB promotes proliferation and metastasis in A549 cells by down-regulation of microRNA-494</article-title>
          <source>J. Cell. Biochem.</source>
          <year>2018</year>
          <volume>119</volume>
          <fpage>6935</fpage>
          <lpage>6942</lpage>
          <pub-id pub-id-type="doi">10.1002/jcb.26894</pub-id>
          <pub-id pub-id-type="pmid">29693289</pub-id>
        </element-citation>
      </ref>
      <ref id="B114-ijms-21-01193">
        <label>114.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ke</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>M.Q.</given-names>
            </name>
          </person-group>
          <article-title>High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer</article-title>
          <source>Clin. Transl. Oncol.</source>
          <year>2017</year>
          <volume>19</volume>
          <fpage>599</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="doi">10.1007/s12094-016-1572-3</pub-id>
          <pub-id pub-id-type="pmid">27878433</pub-id>
        </element-citation>
      </ref>
      <ref id="B115-ijms-21-01193">
        <label>115.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Che</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mao</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The TGF&#x3B2;-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling</article-title>
          <source>Cancer Lett.</source>
          <year>2018</year>
          <volume>432</volume>
          <fpage>156</fpage>
          <lpage>168</lpage>
          <pub-id pub-id-type="doi">10.1016/j.canlet.2018.06.013</pub-id>
          <pub-id pub-id-type="pmid">29908210</pub-id>
        </element-citation>
      </ref>
      <ref id="B116-ijms-21-01193">
        <label>116.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>TGF-&#x3B2;-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression</article-title>
          <source>Cancer Med.</source>
          <year>2018</year>
          <volume>7</volume>
          <fpage>5118</fpage>
          <lpage>5129</lpage>
          <pub-id pub-id-type="doi">10.1002/cam4.1758</pub-id>
          <pub-id pub-id-type="pmid">30256540</pub-id>
        </element-citation>
      </ref>
      <ref id="B117-ijms-21-01193">
        <label>117.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Long Non-Coding RNA AWPPH Promotes Postoperative Distant Recurrence in Resected Non-Small Cell Lung Cancer by Upregulating Transforming Growth Factor beta 1 (TGF-&#x3B2;1)</article-title>
          <source>Med Sci. Monit. Int. Med J. Exp. Clin. Res.</source>
          <year>2019</year>
          <volume>25</volume>
          <fpage>2535</fpage>
          <lpage>2541</lpage>
          <pub-id pub-id-type="doi">10.12659/MSM.912876</pub-id>
        </element-citation>
      </ref>
      <ref id="B118-ijms-21-01193">
        <label>118.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nan</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Q.</given-names>
            </name>
          </person-group>
          <article-title>LncRNA CASC11 promotes TGF-beta1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer</article-title>
          <source>Gene</source>
          <year>2019</year>
          <volume>704</volume>
          <fpage>91</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gene.2019.04.019</pub-id>
          <pub-id pub-id-type="pmid">30965130</pub-id>
        </element-citation>
      </ref>
      <ref id="B119-ijms-21-01193">
        <label>119.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miao</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>LncRNA HAND2-AS1 inhibits non-small cell lung cancer migration, invasion and maintains cell stemness through the interactions with TGF-&#x3B2;1</article-title>
          <source>Biosci. Rep.</source>
          <year>2019</year>
          <volume>39</volume>
          <pub-id pub-id-type="doi">10.1042/BSR20181525</pub-id>
        </element-citation>
      </ref>
      <ref id="B120-ijms-21-01193">
        <label>120.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Long noncoding RNA LINC01186, regulated by TGF-beta/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer</article-title>
          <source>Gene</source>
          <year>2017</year>
          <volume>608</volume>
          <fpage>1</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gene.2017.01.023</pub-id>
          <pub-id pub-id-type="pmid">28119085</pub-id>
        </element-citation>
      </ref>
      <ref id="B121-ijms-21-01193">
        <label>121.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Teng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>TGF-beta/SMAD4-Regulated LncRNA-LINP1 Inhibits Epithelial-Mesenchymal Transition in Lung Cancer</article-title>
          <source>Int. J. Biol. Sci.</source>
          <year>2018</year>
          <volume>14</volume>
          <fpage>1715</fpage>
          <lpage>1723</lpage>
          <pub-id pub-id-type="doi">10.7150/ijbs.27197</pub-id>
          <pub-id pub-id-type="pmid">30416386</pub-id>
        </element-citation>
      </ref>
      <ref id="B122-ijms-21-01193">
        <label>122.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lan</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>lncRA ANCR Inhibits Non-Small Cell Lung Cancer Cell Migration and Invasion by Inactivating TGF-beta Pathway</article-title>
          <source>Med. Sci. Monit. Int. Med. J. Exp. Clin. Res.</source>
          <year>2018</year>
          <volume>24</volume>
          <fpage>6002</fpage>
          <lpage>6009</lpage>
          <pub-id pub-id-type="doi">10.12659/msm.911492</pub-id>
        </element-citation>
      </ref>
      <ref id="B123-ijms-21-01193">
        <label>123.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Che</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-&#x3BA;B/Snail pathway</article-title>
          <source>J. Exp. Clin. Cancer Res.</source>
          <year>2017</year>
          <volume>36</volume>
          <fpage>54</fpage>
          <pub-id pub-id-type="doi">10.1186/s13046-017-0518-0</pub-id>
          <pub-id pub-id-type="pmid">28412955</pub-id>
        </element-citation>
      </ref>
      <ref id="B124-ijms-21-01193">
        <label>124.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iqbal</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Arora</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Prakasam</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Calin</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Syed</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA in lung cancer: Role, mechanisms, pathways and therapeutic relevance</article-title>
          <source>Mol. Asp. Med.</source>
          <year>2019</year>
          <volume>70</volume>
          <fpage>3</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mam.2018.07.003</pub-id>
        </element-citation>
      </ref>
      <ref id="B125-ijms-21-01193">
        <label>125.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ergun</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Oztuzcu</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways</article-title>
          <source>Tumour Biol.</source>
          <year>2015</year>
          <volume>36</volume>
          <fpage>3129</fpage>
          <lpage>3136</lpage>
          <pub-id pub-id-type="doi">10.1007/s13277-015-3346-x</pub-id>
          <pub-id pub-id-type="pmid">25809705</pub-id>
        </element-citation>
      </ref>
      <ref id="B126-ijms-21-01193">
        <label>126.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Panda</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>Circular RNAs Act as miRNA Sponges</article-title>
          <source>Adv. Exp. Med. Biol.</source>
          <year>2018</year>
          <volume>1087</volume>
          <fpage>67</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="doi">10.1007/978-981-13-1426-1_6</pub-id>
          <pub-id pub-id-type="pmid">30259358</pub-id>
        </element-citation>
      </ref>
      <ref id="B127-ijms-21-01193">
        <label>127.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Progress in research on the role of circular RNAs in lung cancer</article-title>
          <source>World J. Surg. Oncol.</source>
          <year>2018</year>
          <volume>16</volume>
          <fpage>215</fpage>
          <pub-id pub-id-type="doi">10.1186/s12957-018-1515-2</pub-id>
          <pub-id pub-id-type="pmid">30400981</pub-id>
        </element-citation>
      </ref>
      <ref id="B128-ijms-21-01193">
        <label>128.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Bi</surname>
              <given-names>Z.-Y.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Z.-L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.-L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y.-Y.-Y.</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>B.-T.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emerging landscape of circular RNAs in lung cancer</article-title>
          <source>Cancer Lett.</source>
          <year>2018</year>
          <volume>427</volume>
          <fpage>18</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1016/j.canlet.2018.04.006</pub-id>
          <pub-id pub-id-type="pmid">29653267</pub-id>
        </element-citation>
      </ref>
      <ref id="B129-ijms-21-01193">
        <label>129.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-&#x3B2; pathway in NSCLC</article-title>
          <source>Oncogene</source>
          <year>2019</year>
          <volume>38</volume>
          <fpage>896</fpage>
          <lpage>912</lpage>
          <pub-id pub-id-type="doi">10.1038/s41388-018-0484-9</pub-id>
          <pub-id pub-id-type="pmid">30181549</pub-id>
        </element-citation>
      </ref>
      <ref id="B130-ijms-21-01193">
        <label>130.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Armenteros-Monterroso</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>East</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Chakravorty</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Winslow</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Downward</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>HMGA2 functions as a competing endogenous RNA to promote lung cancer progression</article-title>
          <source>Nature</source>
          <year>2014</year>
          <volume>505</volume>
          <fpage>212</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="doi">10.1038/nature12785</pub-id>
          <pub-id pub-id-type="pmid">24305048</pub-id>
        </element-citation>
      </ref>
      <ref id="B131-ijms-21-01193">
        <label>131.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Dorn</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Erdjument-Bromage</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tempst</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Massague</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>125</volume>
          <fpage>929</fpage>
          <lpage>941</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2006.03.045</pub-id>
          <pub-id pub-id-type="pmid">16751102</pub-id>
        </element-citation>
      </ref>
      <ref id="B132-ijms-21-01193">
        <label>132.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-&#x3B2;-induced epithelial-mesenchymal transition and metastasis by controlling TIF1gamma in non-small cell lung cancer</article-title>
          <source>Mol. Cancer</source>
          <year>2018</year>
          <volume>17</volume>
          <fpage>140</fpage>
          <pub-id pub-id-type="doi">10.1186/s12943-018-0889-7</pub-id>
          <pub-id pub-id-type="pmid">30261900</pub-id>
        </element-citation>
      </ref>
      <ref id="B133-ijms-21-01193">
        <label>133.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhan</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Jiao</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Q.Y.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion</article-title>
          <source>Thorac. Cancer</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>461</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="doi">10.1111/1759-7714.12467</pub-id>
          <pub-id pub-id-type="pmid">28660665</pub-id>
        </element-citation>
      </ref>
      <ref id="B134-ijms-21-01193">
        <label>134.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scagliotti</surname>
              <given-names>G.V.</given-names>
            </name>
          </person-group>
          <article-title>Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer</article-title>
          <source>Semin. Oncol.</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>S5</fpage>
          <lpage>S8</lpage>
          <pub-id pub-id-type="doi">10.1053/j.seminoncol.2005.02.006</pub-id>
          <pub-id pub-id-type="pmid">15818537</pub-id>
        </element-citation>
      </ref>
      <ref id="B135-ijms-21-01193">
        <label>135.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>H.B.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>G.N.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-21 Regulates Non-Small Cell Lung Cancer Cell Invasion and Chemo-Sensitivity through SMAD7</article-title>
          <source>Cell. Physiol. Biochem.</source>
          <year>2016</year>
          <volume>38</volume>
          <fpage>2152</fpage>
          <lpage>2162</lpage>
          <pub-id pub-id-type="doi">10.1159/000445571</pub-id>
          <pub-id pub-id-type="pmid">27185036</pub-id>
        </element-citation>
      </ref>
      <ref id="B136-ijms-21-01193">
        <label>136.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Jing</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFbetaR1/Smad signaling pathway in NSCLC</article-title>
          <source>Sci. Rep.</source>
          <year>2015</year>
          <volume>5</volume>
          <fpage>17618</fpage>
          <pub-id pub-id-type="doi">10.1038/srep17618</pub-id>
          <pub-id pub-id-type="pmid">26620926</pub-id>
        </element-citation>
      </ref>
      <ref id="B137-ijms-21-01193">
        <label>137.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Mo</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC</article-title>
          <source>PLoS ONE</source>
          <year>2014</year>
          <volume>9</volume>
          <elocation-id>e94639</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0094639</pub-id>
          <pub-id pub-id-type="pmid">24722426</pub-id>
        </element-citation>
      </ref>
      <ref id="B138-ijms-21-01193">
        <label>138.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Decitabine reverses TGF-beta1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis</article-title>
          <source>Drug Des. Dev. Ther.</source>
          <year>2017</year>
          <volume>11</volume>
          <fpage>969</fpage>
          <lpage>983</lpage>
          <pub-id pub-id-type="doi">10.2147/DDDT.S129305</pub-id>
        </element-citation>
      </ref>
      <ref id="B139-ijms-21-01193">
        <label>139.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tong</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>LncRNA CASC11 promotes the development of lung cancer through targeting microRNA-302/CDK1 axis</article-title>
          <source>Eur. Rev. Med Pharmacol. Sci.</source>
          <year>2019</year>
          <volume>23</volume>
          <fpage>6539</fpage>
          <lpage>6547</lpage>
          <pub-id pub-id-type="doi">10.26355/eurrev_201908_18539</pub-id>
          <pub-id pub-id-type="pmid">31378894</pub-id>
        </element-citation>
      </ref>
      <ref id="B140-ijms-21-01193">
        <label>140.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donatelli</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J.-M.</given-names>
            </name>
            <name>
              <surname>Gilvary</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Eksioglu</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Cress</surname>
              <given-names>W.D.</given-names>
            </name>
            <name>
              <surname>Haura</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>Schabath</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Coppola</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TGF-&#x3B2;-inducible microRNA-183 silences tumor-associated natural killer cells</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2014</year>
          <volume>111</volume>
          <fpage>4203</fpage>
          <lpage>4208</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1319269111</pub-id>
          <pub-id pub-id-type="pmid">24586048</pub-id>
        </element-citation>
      </ref>
      <ref id="B141-ijms-21-01193">
        <label>141.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weber</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Johnen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Casjens</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bryk</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Pesch</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Jockel</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Kollmeier</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bruning</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer</article-title>
          <source>BMC Res. Notes</source>
          <year>2013</year>
          <volume>6</volume>
          <elocation-id>518</elocation-id>
          <pub-id pub-id-type="doi">10.1186/1756-0500-6-518</pub-id>
          <pub-id pub-id-type="pmid">24313945</pub-id>
        </element-citation>
      </ref>
      <ref id="B142-ijms-21-01193">
        <label>142.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sui</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Qu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Upregulated miRNA-182-5p expression in tumor tissue and peripheral blood samples from patients with non-small cell lung cancer is associated with downregulated Caspase 2 expression</article-title>
          <source>Exp. Ther. Med.</source>
          <year>2020</year>
          <volume>19</volume>
          <fpage>603</fpage>
          <lpage>610</lpage>
          <pub-id pub-id-type="doi">10.3892/etm.2019.8074</pub-id>
          <pub-id pub-id-type="pmid">31897103</pub-id>
        </element-citation>
      </ref>
      <ref id="B143-ijms-21-01193">
        <label>143.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Investigation of LINC00342 as a poor prognostic biomarker for human patients with non-small cell lung cancer</article-title>
          <source>J. Cell. Biochem.</source>
          <year>2019</year>
          <volume>120</volume>
          <fpage>5055</fpage>
          <lpage>5061</lpage>
          <pub-id pub-id-type="doi">10.1002/jcb.27782</pub-id>
          <pub-id pub-id-type="pmid">30320899</pub-id>
        </element-citation>
      </ref>
      <ref id="B144-ijms-21-01193">
        <label>144.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kwok</surname>
              <given-names>H.-H.</given-names>
            </name>
            <name>
              <surname>Ning</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>P.W.-C.</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>T.S.-K.</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>M.H.-L.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>G.Y.F.</given-names>
            </name>
            <name>
              <surname>Ip</surname>
              <given-names>M.S.-M.</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>D.C.-L.</given-names>
            </name>
          </person-group>
          <article-title>Transfer of Extracellular Vesicle-Associated-RNAs Induces Drug Resistance in ALK-Translocated Lung Adenocarcinoma</article-title>
          <source>Cancers</source>
          <year>2019</year>
          <volume>11</volume>
          <elocation-id>104</elocation-id>
          <pub-id pub-id-type="doi">10.3390/cancers11010104</pub-id>
          <pub-id pub-id-type="pmid">30658414</pub-id>
        </element-citation>
      </ref>
      <ref id="B145-ijms-21-01193">
        <label>145.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mei</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7</article-title>
          <source>J. Cell. Mol. Med.</source>
          <year>2017</year>
          <volume>21</volume>
          <fpage>1228</fpage>
          <lpage>1236</lpage>
          <pub-id pub-id-type="doi">10.1111/jcmm.13056</pub-id>
          <pub-id pub-id-type="pmid">28026121</pub-id>
        </element-citation>
      </ref>
      <ref id="B146-ijms-21-01193">
        <label>146.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>&#x15A;witlik</surname>
              <given-names>W.Z.</given-names>
            </name>
            <name>
              <surname>Karbownik</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Suwalski</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kozak</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Szemraj</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study</article-title>
          <source>Genet. Test. Mol. Biomark.</source>
          <year>2019</year>
          <volume>23</volume>
          <fpage>353</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="doi">10.1089/gtmb.2018.0275</pub-id>
        </element-citation>
      </ref>
      <ref id="B147-ijms-21-01193">
        <label>147.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>X.B.</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Jing</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ning</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung Cancer</article-title>
          <source>Dis. Markers</source>
          <year>2017</year>
          <volume>2017</volume>
          <fpage>7439698</fpage>
          <pub-id pub-id-type="doi">10.1155/2017/7439698</pub-id>
          <pub-id pub-id-type="pmid">29375177</pub-id>
        </element-citation>
      </ref>
      <ref id="B148-ijms-21-01193">
        <label>148.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lv</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor-tyrosine kinase inhibitor therapy</article-title>
          <source>Thorac. Cancer</source>
          <year>2020</year>
          <volume>11</volume>
          <fpage>29</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1111/1759-7714.13216</pub-id>
          <pub-id pub-id-type="pmid">31691525</pub-id>
        </element-citation>
      </ref>
      <ref id="B149-ijms-21-01193">
        <label>149.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>W.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnostic Value of Plasma MicroRNAs for Lung Cancer Using Support Vector Machine Model</article-title>
          <source>J. Cancer</source>
          <year>2019</year>
          <volume>10</volume>
          <fpage>5090</fpage>
          <lpage>5098</lpage>
          <pub-id pub-id-type="doi">10.7150/jca.30528</pub-id>
          <pub-id pub-id-type="pmid">31602261</pub-id>
        </element-citation>
      </ref>
      <ref id="B150-ijms-21-01193">
        <label>150.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hojbjerg</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Ebert</surname>
              <given-names>E.B.F.</given-names>
            </name>
            <name>
              <surname>Clement</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Winther-Larsen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Meldgaard</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sorensen</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients</article-title>
          <source>Lung Cancer (Amst. Neth.)</source>
          <year>2019</year>
          <volume>135</volume>
          <fpage>92</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lungcan.2019.07.005</pub-id>
        </element-citation>
      </ref>
      <ref id="B151-ijms-21-01193">
        <label>151.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y.L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Z.L.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X.B.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.Y.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>X.W.</given-names>
            </name>
          </person-group>
          <article-title>Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer</article-title>
          <source>Eur. Rev. Med. Pharmacol. Sci.</source>
          <year>2019</year>
          <volume>23</volume>
          <fpage>5251</fpage>
          <lpage>5259</lpage>
          <pub-id pub-id-type="doi">10.26355/eurrev_201906_18191</pub-id>
          <pub-id pub-id-type="pmid">31298376</pub-id>
        </element-citation>
      </ref>
      <ref id="B152-ijms-21-01193">
        <label>152.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma</article-title>
          <source>Oncotarget</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>26070</fpage>
          <lpage>26086</lpage>
          <pub-id pub-id-type="doi">10.18632/oncotarget.8429</pub-id>
          <pub-id pub-id-type="pmid">27036025</pub-id>
        </element-citation>
      </ref>
      <ref id="B153-ijms-21-01193">
        <label>153.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stass</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Sputum long non-coding RNA biomarkers for diagnosis of lung cancer</article-title>
          <source>Cancer Biomark. Sect. A Dis. Mark.</source>
          <year>2019</year>
          <volume>26</volume>
          <fpage>219</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="doi">10.3233/CBM-190161</pub-id>
          <pub-id pub-id-type="pmid">31450489</pub-id>
        </element-citation>
      </ref>
      <ref id="B154-ijms-21-01193">
        <label>154.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Leng</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C.-J.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer</article-title>
          <source>Biomark Cancer</source>
          <year>2018</year>
          <volume>10</volume>
          <pub-id pub-id-type="doi">10.1177/1179299X18759297</pub-id>
        </element-citation>
      </ref>
      <ref id="B155-ijms-21-01193">
        <label>155.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>W.W.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y.J.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>W.G.</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>Y.S.</given-names>
            </name>
          </person-group>
          <article-title>Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer</article-title>
          <source>Oncotargets Ther.</source>
          <year>2018</year>
          <volume>11</volume>
          <fpage>2333</fpage>
          <lpage>2344</lpage>
          <pub-id pub-id-type="doi">10.2147/OTT.S157551</pub-id>
          <pub-id pub-id-type="pmid">29731641</pub-id>
        </element-citation>
      </ref>
      <ref id="B156-ijms-21-01193">
        <label>156.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hydbring</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>De Petris</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Brand&#xE9;n</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Koyi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Novak</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kanter</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>H&#xE5;&#xE5;g</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hurley</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tadigotla</surname>
              <given-names>V.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression</article-title>
          <source>Lung Cancer (Amst. Neth.)</source>
          <year>2018</year>
          <volume>124</volume>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1016/j.lungcan.2018.07.018</pub-id>
        </element-citation>
      </ref>
      <ref id="B157-ijms-21-01193">
        <label>157.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Eom</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>W.Y.</given-names>
            </name>
            <name>
              <surname>Jo</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Mok</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>K.U.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M.H.</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study</article-title>
          <source>Thorac. Cancer</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>911</fpage>
          <lpage>915</lpage>
          <pub-id pub-id-type="doi">10.1111/1759-7714.12756</pub-id>
          <pub-id pub-id-type="pmid">29806739</pub-id>
        </element-citation>
      </ref>
      <ref id="B158-ijms-21-01193">
        <label>158.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ning</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway</article-title>
          <source>Oxid. Med. Cell Longev.</source>
          <year>2019</year>
          <volume>2019</volume>
          <fpage>9719723</fpage>
          <pub-id pub-id-type="doi">10.1155/2019/9719723</pub-id>
          <pub-id pub-id-type="pmid">31316723</pub-id>
        </element-citation>
      </ref>
      <ref id="B159-ijms-21-01193">
        <label>159.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7</article-title>
          <source>Oncotargets Ther.</source>
          <year>2018</year>
          <volume>11</volume>
          <fpage>8445</fpage>
          <lpage>8454</lpage>
          <pub-id pub-id-type="doi">10.2147/OTT.S172393</pub-id>
        </element-citation>
      </ref>
      <ref id="B160-ijms-21-01193">
        <label>160.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hetta</surname>
              <given-names>H.F.</given-names>
            </name>
            <name>
              <surname>Zahran</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Shafik</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>El-Mahdy</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Mohamed</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Nabil</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Esmaeel</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Alkady</surname>
              <given-names>O.A.</given-names>
            </name>
            <name>
              <surname>Elkady</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mohareb</surname>
              <given-names>D.A.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer</article-title>
          <source>Microrna</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>206</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.2174/1573399815666190115151500</pub-id>
          <pub-id pub-id-type="pmid">30652656</pub-id>
        </element-citation>
      </ref>
      <ref id="B161-ijms-21-01193">
        <label>161.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Expression Promotes Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer via ERK/Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway</article-title>
          <source>Med. Sci. Monit. Int. Med. J. Exp. Clin. Res.</source>
          <year>2019</year>
          <volume>25</volume>
          <fpage>5143</fpage>
          <lpage>5149</lpage>
          <pub-id pub-id-type="doi">10.12659/MSM.913308</pub-id>
          <pub-id pub-id-type="pmid">31293277</pub-id>
        </element-citation>
      </ref>
      <ref id="B162-ijms-21-01193">
        <label>162.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis</article-title>
          <source>Int. J. Immunopathol. Pharm.</source>
          <year>2019</year>
          <volume>33</volume>
          <pub-id pub-id-type="doi">10.1177/2058738419859699</pub-id>
          <pub-id pub-id-type="pmid">31240979</pub-id>
        </element-citation>
      </ref>
      <ref id="B163-ijms-21-01193">
        <label>163.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ming</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2017</year>
          <volume>490</volume>
          <fpage>406</fpage>
          <lpage>414</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.06.055</pub-id>
          <pub-id pub-id-type="pmid">28623135</pub-id>
        </element-citation>
      </ref>
      <ref id="B164-ijms-21-01193">
        <label>164.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>P.-P.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.-Q.</given-names>
            </name>
            <name>
              <surname>Weng</surname>
              <given-names>W.-W.</given-names>
            </name>
            <name>
              <surname>Nie</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>M.-D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C.-F.</given-names>
            </name>
          </person-group>
          <article-title>Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma</article-title>
          <source>J. Cancer</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>2042</fpage>
          <lpage>2050</lpage>
          <pub-id pub-id-type="doi">10.7150/jca.18852</pub-id>
          <pub-id pub-id-type="pmid">28819405</pub-id>
        </element-citation>
      </ref>
      <ref id="B165-ijms-21-01193">
        <label>165.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Q.F.</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p</article-title>
          <source>Eur. Rev. Med. Pharmacol. Sci.</source>
          <year>2019</year>
          <volume>23</volume>
          <fpage>7408</fpage>
          <lpage>7418</lpage>
          <pub-id pub-id-type="doi">10.26355/eurrev_201909_18849</pub-id>
          <pub-id pub-id-type="pmid">31539128</pub-id>
        </element-citation>
      </ref>
      <ref id="B166-ijms-21-01193">
        <label>166.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stieber</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hasholzner</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Bodenm&#xFC;ller</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nagel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Sunder-Plassmann</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dienemann</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Meier</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Fateh-Moghadam</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>CYFRA 21-1. A new marker in lung cancer</article-title>
          <source>Cancer</source>
          <year>1993</year>
          <volume>72</volume>
          <fpage>707</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19930801)72:3&lt;707::AID-CNCR2820720313&gt;3.0.CO;2-X</pub-id>
          <pub-id pub-id-type="pmid">7687515</pub-id>
        </element-citation>
      </ref>
      <ref id="B167-ijms-21-01193">
        <label>167.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Miguel-P&#xE9;rez</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bayarri-Lara</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Ortega</surname>
              <given-names>F.G.</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Moyano Rodriguez</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Alvarez-Cubero</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Maza Serrano</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Lorente</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Rolfo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Serrano</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma</article-title>
          <source>Cancers</source>
          <year>2019</year>
          <volume>11</volume>
          <elocation-id>1750</elocation-id>
          <pub-id pub-id-type="doi">10.3390/cancers11111750</pub-id>
        </element-citation>
      </ref>
      <ref id="B168-ijms-21-01193">
        <label>168.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Economopoulou</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Georgoulias</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Kotsakis</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Classifying circulating tumor cells to monitor cancer progression</article-title>
          <source>Exp. Rev. Mol. Diagn.</source>
          <year>2017</year>
          <volume>17</volume>
          <fpage>153</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="doi">10.1080/14737159.2017.1275572</pub-id>
        </element-citation>
      </ref>
      <ref id="B169-ijms-21-01193">
        <label>169.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Son</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jeon</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J.-H.</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>G.-R.</given-names>
            </name>
            <name>
              <surname>Youn</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Nam</surname>
              <given-names>S.Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy</article-title>
          <source>Mol. Ther.</source>
          <year>2019</year>
          <volume>27</volume>
          <fpage>342</fpage>
          <lpage>354</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ymthe.2018.10.015</pub-id>
          <pub-id pub-id-type="pmid">30424954</pub-id>
        </element-citation>
      </ref>
      <ref id="B170-ijms-21-01193">
        <label>170.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mao</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Radiotherapy induced Lewis lung cancer cell apoptosis via inactivating &#x3B2;-catenin mediated by upregulated HOTAIR</article-title>
          <source>Int. J. Clin. Exp. Pathol.</source>
          <year>2015</year>
          <volume>8</volume>
          <fpage>7878</fpage>
          <lpage>7886</lpage>
          <pub-id pub-id-type="pmid">26339352</pub-id>
        </element-citation>
      </ref>
      <ref id="B171-ijms-21-01193">
        <label>171.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Tao</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2018</year>
          <volume>504</volume>
          <fpage>123</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.08.142</pub-id>
          <pub-id pub-id-type="pmid">30173893</pub-id>
        </element-citation>
      </ref>
      <ref id="B172-ijms-21-01193">
        <label>172.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yuwen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy</article-title>
          <source>Int. J. Nanomed.</source>
          <year>2019</year>
          <volume>14</volume>
          <fpage>8121</fpage>
          <lpage>8132</lpage>
          <pub-id pub-id-type="doi">10.2147/IJN.S221383</pub-id>
        </element-citation>
      </ref>
      <ref id="B173-ijms-21-01193">
        <label>173.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#x2019;Almeida</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Mothar</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Bondzie</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Lieumo</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tagne</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Volkert</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tagne</surname>
              <given-names>J.-B.</given-names>
            </name>
          </person-group>
          <article-title>Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells</article-title>
          <source>BMC Cancer</source>
          <year>2019</year>
          <volume>19</volume>
          <elocation-id>136</elocation-id>
          <pub-id pub-id-type="doi">10.1186/s12885-019-5337-6</pub-id>
          <pub-id pub-id-type="pmid">30744585</pub-id>
        </element-citation>
      </ref>
      <ref id="B174-ijms-21-01193">
        <label>174.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rana</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Z&#xF6;ller</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Exosome target cell selection and the importance of exosomal tetraspanins: A hypothesis</article-title>
          <source>Biochem. Soc. Trans.</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>559</fpage>
          <lpage>562</lpage>
          <pub-id pub-id-type="doi">10.1042/BST0390559</pub-id>
          <pub-id pub-id-type="pmid">21428939</pub-id>
        </element-citation>
      </ref>
      <ref id="B175-ijms-21-01193">
        <label>175.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoshino</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Costa-Silva</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>T.-L.</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tesic Mark</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kohsaka</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Di Giannatale</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ceder</surname>
              <given-names>S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tumour exosome integrins determine organotropic metastasis</article-title>
          <source>Nature</source>
          <year>2015</year>
          <volume>527</volume>
          <fpage>329</fpage>
          <lpage>335</lpage>
          <pub-id pub-id-type="doi">10.1038/nature15756</pub-id>
          <pub-id pub-id-type="pmid">26524530</pub-id>
        </element-citation>
      </ref>
      <ref id="B176-ijms-21-01193">
        <label>176.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srivastava</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Amreddy</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Razaq</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Towner</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.D.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Munshi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ramesh</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Exosomes as Theranostics for Lung Cancer</article-title>
          <source>Adv. Cancer Res.</source>
          <year>2018</year>
          <volume>139</volume>
          <fpage>1</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1016/bs.acr.2018.04.001</pub-id>
          <pub-id pub-id-type="pmid">29941101</pub-id>
        </element-citation>
      </ref>
      <ref id="B177-ijms-21-01193">
        <label>177.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mo</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin</article-title>
          <source>Biotechnol. Lett.</source>
          <year>2017</year>
          <volume>39</volume>
          <fpage>701</fpage>
          <lpage>710</lpage>
          <pub-id pub-id-type="doi">10.1007/s10529-017-2290-9</pub-id>
          <pub-id pub-id-type="pmid">28120164</pub-id>
        </element-citation>
      </ref>
      <ref id="B178-ijms-21-01193">
        <label>178.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>V&#xE1;zquez-R&#xED;os</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Molina-Crespo</surname>
              <given-names>&#xC1;.</given-names>
            </name>
            <name>
              <surname>Bouzo</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez-L&#xF3;pez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Moreno-Bueno</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>de la Fuente</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Exosome-mimetic nanoplatforms for targeted cancer drug delivery</article-title>
          <source>J. Nanobiotechnol.</source>
          <year>2019</year>
          <volume>17</volume>
          <fpage>85</fpage>
          <pub-id pub-id-type="doi">10.1186/s12951-019-0517-8</pub-id>
        </element-citation>
      </ref>
      <ref id="B179-ijms-21-01193">
        <label>179.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Grimmett</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Domalewski</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases</article-title>
          <source>Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.</source>
          <year>2020</year>
          <volume>12</volume>
          <fpage>e1586</fpage>
          <pub-id pub-id-type="doi">10.1002/wnan.1586</pub-id>
          <pub-id pub-id-type="pmid">31602823</pub-id>
        </element-citation>
      </ref>
      <ref id="B180-ijms-21-01193">
        <label>180.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garbuzenko</surname>
              <given-names>O.B.</given-names>
            </name>
            <name>
              <surname>Kuzmov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Taratula</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Pine</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Minko</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Strategy to enhance lung cancer treatment by five essential elements: Inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy</article-title>
          <source>Theranostics</source>
          <year>2019</year>
          <volume>9</volume>
          <fpage>8362</fpage>
          <lpage>8376</lpage>
          <pub-id pub-id-type="doi">10.7150/thno.39816</pub-id>
          <pub-id pub-id-type="pmid">31754402</pub-id>
        </element-citation>
      </ref>
      <ref id="B181-ijms-21-01193">
        <label>181.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Biofabrication of nano copper oxide and its aptamer bioconjugate for delivery of mRNA 29b to lung cancer cells</article-title>
          <source>Mater. Sci. Eng. C Mater. Biol. Appl.</source>
          <year>2019</year>
          <volume>97</volume>
          <fpage>827</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="doi">10.1016/j.msec.2018.12.009</pub-id>
          <pub-id pub-id-type="pmid">30678973</pub-id>
        </element-citation>
      </ref>
      <ref id="B182-ijms-21-01193">
        <label>182.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN</article-title>
          <source>J. Exp. Clin. Cancer Res. Cr</source>
          <year>2015</year>
          <volume>34</volume>
          <fpage>59</fpage>
          <pub-id pub-id-type="doi">10.1186/s13046-015-0169-y</pub-id>
          <pub-id pub-id-type="pmid">26063204</pub-id>
        </element-citation>
      </ref>
      <ref id="B183-ijms-21-01193">
        <label>183.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sessa</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hata</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Role of microRNAs in lung development and pulmonary diseases</article-title>
          <source>Pulm. Circ.</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>315</fpage>
          <lpage>328</lpage>
          <pub-id pub-id-type="doi">10.4103/2045-8932.114758</pub-id>
          <pub-id pub-id-type="pmid">24015331</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="ijms-21-01193-f001" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>TGF-&#x3B2; signaling regulates lung cancer cell invasion and migration. TGF-&#x3B2; can mediate EMT via Smad pathways and non-Smad pathways. TGF-&#x3B2; can increase Snail, Slug, and ZEB2 expression to decrease E-cadherin. It can also bind to TGFBR2 and then phosphorylate Par6 to recruit Smad ubiquitin regulatory factor 1 (SMURF1). SMURF1 can degrade RhoA. These can reduce cell&#x2013;cell adhesion. TGF-&#x3B2;1 can activate PI3K/AKT/NF-&#x3BA;B to increase &#x3B2;1 integrin expression. TGF-&#x3B2;/Smad3 signal can increase &#x3B1;5&#x3B2;1 integrin expression by down-regulating zyxin. These can enhance cell&#x2013;matrix adhesion. TGF-&#x3B2; can increase phosphorylated focal adhesion kinase (pFAK), Src, cortactin, and ERK in response to &#x3B2;3 integrin, resulting in forming a mature invadopodia.</p>
      </caption>
      <graphic xlink:href="ijms-21-01193-g001"/>
    </fig>
    <fig id="ijms-21-01193-f002" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>TGF-&#x3B2; signaling regulates lung cancer&#x2019;s distant metastasis. TGF-&#x3B2; can increase &#x3B2;3 integrin expression to enhance cancer cell intravasation. TGF-&#x3B2; can increase Tregs via Cox-2/PGE2 to suppress the proliferation of CD4+ T cells, thus driving lung CTCs to escape from immune attacks. TGF-&#x3B2; can induce miR-183 to down-regulate MICA and MICB expression, which can help cancer cells evade immune detection. TGF-&#x3B2;1/Smad2 can up-regulate PD-L1. PD-L1 can bind to PD-1 to suppress anti-tumor immunity. TGF-&#x3B2;/Smad3 can induce dedicator of cytokinesis 4 (DOCK4) expression to activate Rac1. Then, Rac1 activation can promote cancer cell extravasation. TGF-&#x3B2;/Smad2/3 is required for the combination of histone deacetylase 4 (HDAC4), paired-like homeodomain 1 (PITX1), and roundabout, axon guidance receptor, and homolog 1 (ROBO1), which can promote the bone colonization of lung cancer cells. TGF-&#x3B2; can increase transcription factor 4 (TCF4), protein kinase D 3 (PRKD3), and SUSD5 levels, which can also enhance bone colonization.</p>
      </caption>
      <graphic xlink:href="ijms-21-01193-g002"/>
    </fig>
    <fig id="ijms-21-01193-f003" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>TGF-&#x3B2; regulates lung cancer metastasis via exosomes. TGF-&#x3B2; can affect lung tumor cell invasion, migration, and metastasis by modulating the cargo carried by A549 cell-derived exosomes. In this process, TGF-&#x3B2; can decrease E-cadherin and increase &#x3B2;-catenin, miR-23a and lnc-MMP2-2. Decreased E-cadherin and increased &#x3B2;-catenin can then promote EMT. Increased miR-23a can decrease E-cadherin to enhance EMT. Up-regulated lnc-MMP2-2 can inhibit E-cadherin, as well as increase N-cadherin and vimentin to promote invasion and migration; it can also increase vascular permeability by repressing occludin and Zo-1. Moreover, lnc-MMP2-2 can augment MMP2 to accelerate metastasis.</p>
      </caption>
      <graphic xlink:href="ijms-21-01193-g003"/>
    </fig>
    <table-wrap id="ijms-21-01193-t001" orientation="portrait" position="float">
      <object-id pub-id-type="pii">ijms-21-01193-t001_Table 1</object-id>
      <label>Table 1</label>
      <caption>
        <p>The positive roles of miRNAs and lncRNAs in TGF-&#x3B2; signaling-regulated lung cancer metastasis.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nc-RNA</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Roles</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-93</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, H1650</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-93&#x2192;NEDD4L&#x2193;&#x2192;TGF-&#x3B2;/Smad2 signal&#x2191;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B59-ijms-21-01193" ref-type="bibr">59</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-128-3p</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-128-3p&#x2192;SMURF2&#x2193;, cPP1&#x2193;&#x2192;TGF-&#x3B2; signal&#x2191;&#x2192;EMT&#x2191;, metastasis&#x2191;, chemoresistance&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B61-ijms-21-01193" ref-type="bibr">61</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-9</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-9&#x2192;E-cadherin&#x2193;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B62-ijms-21-01193" ref-type="bibr">62</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-23a</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-23a&#x2192;E-cadherin&#x2193;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B74-ijms-21-01193" ref-type="bibr">74</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-134, miR-487b</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-134, miR-487b&#x2192;MAGI2&#x2193;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B65-ijms-21-01193" ref-type="bibr">65</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-330-3p</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">NCI-H1975</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-330-3p&#x2192;E-cadherin&#x2193;, vimentin&#x2191;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B67-ijms-21-01193" ref-type="bibr">67</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-1246</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-1246&#x2192;E-cadherin&#x2193;, vimentin&#x2191;, TGF-&#x3B2;&#x2191;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B68-ijms-21-01193" ref-type="bibr">68</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-9</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, HCC827</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-9&#x2192;SOX7&#x2193;&#x2192;invasion&#x2191;, adhesion&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B63-ijms-21-01193" ref-type="bibr">63</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-9-5p</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, SK-MES-1</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-9-5p&#x2192;TGFBR2&#x2193;&#x2192;invasion&#x2191;, migration&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B71-ijms-21-01193" ref-type="bibr">71</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-181b-5p</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-181b-5p&#x2192;E-cadherin&#x2193;&#x2192;EMT&#x2191;&#x2192;invasion&#x2191;, metastasis&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B73-ijms-21-01193" ref-type="bibr">73</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA HCP5</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">HCP5&#x2192;miR-203&#x2193;&#x2192;Snail&#x2191;, Slug&#x2191;&#x2192;EMT&#x2191;, invasion&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B107-ijms-21-01193" ref-type="bibr">107</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA NORAD</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">NORAD&#x2192;Smad3/importin &#x3B2;1 complex formation&#x2191;&#x2192;TGF-&#x3B2;/Smad2/3 signal&#x2191;&#x2192;<italic>SNAI1</italic>&#x2191;, <italic>FN1</italic>&#x2191;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-ijms-21-01193" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td rowspan="2" align="center" valign="middle" colspan="1">lncRNA XIST</td>
            <td rowspan="2" align="center" valign="middle" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">XIST&#x2192;miR-137&#x2193;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B20-ijms-21-01193" ref-type="bibr">20</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">XIST&#x2192;miR-367&#x2193;, miR-141&#x2193;&#x2192;ZEB2&#x2191;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B19-ijms-21-01193" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA linc00673</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, H1975</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">linc00673&#x2192;miR-150-5p&#x2193;&#x2192;ZEB1&#x2191;&#x2192;EMT&#x2191;, invasion&#x2191;, migration&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B109-ijms-21-01193" ref-type="bibr">109</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA MEG3</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, LC-2/ad</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">MEG3&#x2192;<italic>CDH1</italic>&#x2193;, <italic>miR-200a</italic>&#x2193;, <italic>miR-200c</italic>&#x2193;, <italic>ZEB1</italic>&#x2191;, <italic>ZEB2</italic>&#x2191;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B110-ijms-21-01193" ref-type="bibr">110</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA MEG8</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">MEG8&#x2192;<italic>miR-34a</italic>&#x2193;, <italic>miR-203</italic>&#x2193;&#x2192;<italic>SNAI1</italic>&#x2191;, <italic>SNAI2</italic>&#x2191;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B111-ijms-21-01193" ref-type="bibr">111</xref>]</td>
          </tr>
          <tr>
            <td rowspan="2" align="center" valign="middle" colspan="1">lncRNA ATB</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, HCC827</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">ATB&#x2192;E-cadherin&#x2193;, N-cadherin&#x2191;&#x2192;migration&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B112-ijms-21-01193" ref-type="bibr">112</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">ATB&#x2192;miR-494&#x2193;&#x2192;AKT signal&#x2191;, JAK/STAT3 signal&#x2191;&#x2192;EMT&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B113-ijms-21-01193" ref-type="bibr">113</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA TBILA</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">TBILA&#x2192;HGAL&#x2191;, RhoA&#x2191;, S100A7/ JAB1 signal&#x2191;&#x2192;invasion&#x2191;, migration&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B115-ijms-21-01193" ref-type="bibr">115</xref>]</td>
          </tr>
          <tr>
            <td rowspan="3" align="center" valign="middle" colspan="1">lnc-MMP2-2</td>
            <td rowspan="3" align="center" valign="middle" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">lnc-MMP2-2&#x2192;E-cadherin&#x2193;, N-cadherin&#x2191;, vimentin&#x2191;&#x2192;invasion&#x2191;, migration&#x2191;</td>
            <td rowspan="3" align="center" valign="middle" colspan="1">[<xref rid="B116-ijms-21-01193" ref-type="bibr">116</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lnc-MMP2-2&#x2192;occludin&#x2193;, Zo-1&#x2193;&#x2192;vascular permeability&#x2191;</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lnc-MMP2-2&#x2192;MMP2&#x2191;&#x2192;metastasis&#x2191;</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA AWPPH</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">NCI-H1993, NCI-H2170</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">AWPPH&#x2192;TGF-&#x3B2;1&#x2191;&#x2192;invasion&#x2191;, migration&#x2191;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B117-ijms-21-01193" ref-type="bibr">117</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">lncRNA CASC11</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SHP-77, DMS79</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CASC11&#x2192;TGF-&#x3B2;1&#x2191;&#x2192;stemness&#x2191;</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-ijms-21-01193" ref-type="bibr">118</xref>]</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p><bold>Abbreviations:</bold> nc-RNA, non-coding RNA; miR, microRNA; NEDD4L, Neural precursor cell expressed developmentally downregulated gene 4-like; TGF-&#x3B2;, transforming growth factor-&#x3B2;; EMT, epithelial-mesenchymal transition; SMURF2, Smad ubiquitin regulatory factor 2; cPP1, catalytic subunit of protein phosphatase 1; MAGI2, membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2; SOX7, SRY-Box 7; TGFBR2, TGF-&#x3B2; receptor 2; lncRNA, long non-coding RNA; HCP5, histocompatibility leukocyte antigen complex P5; XIST, X inactivate-specific transcript; ZEB2, Zinc finger E-box-binding homeobox 2; lncRNA-ATB, lncRNA activated by TGF-&#x3B2;; AKT, protein kinase B; JAK, Janus-activated kinase; STAT3, signal transducer and activator of transcription-3; TBILA, TGF-&#x3B2;-induced lncRNA; HGAL, human germinal center-associated lymphoma; JAB1, c-Jun activation domain-binding protein 1; Zo-1, zonula occludens-1; MMP2, matrix metalloprotease 2.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="ijms-21-01193-t002" orientation="portrait" position="float">
      <object-id pub-id-type="pii">ijms-21-01193-t002_Table 2</object-id>
      <label>Table 2</label>
      <caption>
        <p>The negative roles of miRNAs and lncRNAs in TGF-&#x3B2; signaling-regulated lung cancer metastasis.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nc-RNA</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Roles</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-132</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-132&#x2192;TGF-&#x3B2;1/Smad2 signal&#x2193;&#x2192;EMT&#x2193;, invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B77-ijms-21-01193" ref-type="bibr">77</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-203, miR-145</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, 95C</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-203, miR-145&#x2192;Smad3&#x2193;&#x2192;EMT&#x2193;, invasion&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B78-ijms-21-01193" ref-type="bibr">78</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-124</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-124&#x2192;Smad4&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B80-ijms-21-01193" ref-type="bibr">80</xref>]</td>
          </tr>
          <tr>
            <td rowspan="2" align="center" valign="middle" colspan="1">miR-205</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">NCI-H1975</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-205&#x2192;E-cadherin&#x2191;, vimentin&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B67-ijms-21-01193" ref-type="bibr">67</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-205&#x2192;Smad4&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B79-ijms-21-01193" ref-type="bibr">79</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-422a</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">H522</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-422a&#x2192;SULF2&#x2193;&#x2192;TGF-&#x3B2;1/Smad2/3 signal&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B17-ijms-21-01193" ref-type="bibr">17</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-196b</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-196b&#x2192;N-cadherin&#x2193;, vimentin&#x2193;, ZEB1&#x2193;, Snail&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B82-ijms-21-01193" ref-type="bibr">82</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-940</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, H226</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-940&#x2192;Snail&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B83-ijms-21-01193" ref-type="bibr">83</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-22</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Anip973, AGZY83-a</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-22&#x2192;Snail&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B84-ijms-21-01193" ref-type="bibr">84</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-200a</italic>, <italic>miR-200c</italic></td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1"><italic>miR-200a</italic>, <italic>miR-200c</italic>&#x2192;ZEB1&#x2193;, ZEB2&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B85-ijms-21-01193" ref-type="bibr">85</xref>,<xref rid="B86-ijms-21-01193" ref-type="bibr">86</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-145, miR-497</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, H1299</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-145, miR-497&#x2192;MTDH&#x2193;&#x2192;EMT&#x2193;,invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B87-ijms-21-01193" ref-type="bibr">87</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-149</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-149&#x2192;FOXM1&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B88-ijms-21-01193" ref-type="bibr">88</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-134</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-134&#x2192;FOXM1&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B89-ijms-21-01193" ref-type="bibr">89</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-133</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, HCC827</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-133&#x2192;FOXQ1&#x2193;&#x2192;TGF-&#x3B2;&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B90-ijms-21-01193" ref-type="bibr">90</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-29c</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">95C, A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-29c&#x2192;Sp1&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B91-ijms-21-01193" ref-type="bibr">91</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-16</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-16&#x2192;autophagy&#x2191;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B94-ijms-21-01193" ref-type="bibr">94</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-129</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-129&#x2192;SOX4&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B96-ijms-21-01193" ref-type="bibr">96</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-485-5p</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-485-5p&#x2192;E-cadherin&#x2191;, vimentin&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B97-ijms-21-01193" ref-type="bibr">97</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-3127-5p</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, H1299</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-3127-5p&#x2192;E-cadherin&#x2191;, vimentin&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B98-ijms-21-01193" ref-type="bibr">98</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-3607-3p</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">H157, H292</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-3607-3p&#x2192;TGFBR1&#x2193;, CCNE2&#x2193;&#x2192; invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B99-ijms-21-01193" ref-type="bibr">99</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-206, miR-140</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-206, miR-140&#x2192;TGF-&#x3B2;1/Smad3 signal&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;, metastasis&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B100-ijms-21-01193" ref-type="bibr">100</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-136</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549, Calu-3</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-136&#x2192;Smad2&#x2193;, Smad3&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B102-ijms-21-01193" ref-type="bibr">102</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-133a</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-133a&#x2192;TGF-&#x3B2;/TGFBR1 signal&#x2193;&#x2192;AKT signal&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B103-ijms-21-01193" ref-type="bibr">103</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-143</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-143&#x2192;Smad3&#x2193;, CD44&#x2193;, K-Ras&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B104-ijms-21-01193" ref-type="bibr">104</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-886-3p</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">NCI-H446</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-886-3p&#x2192;TGF-&#x3B2;1&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B105-ijms-21-01193" ref-type="bibr">105</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-138</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">LC006, LC021</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">miR-138&#x2192;EMT&#x2193;&#x2192;CSCs formation&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B106-ijms-21-01193" ref-type="bibr">106</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA HAND2-AS1</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">H1581, H1993</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">HAND2-AS1&#x2192;TGF-&#x3B2;1/Smad2/3 signal&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;, stemness&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B119-ijms-21-01193" ref-type="bibr">119</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA linc01186</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">linc01186&#x2192;EMT&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B120-ijms-21-01193" ref-type="bibr">120</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA LINP1</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">A549</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">LINP1&#x2192;E-cadherin&#x2191;, vimentin&#x2193;, Snail&#x2193;&#x2192;EMT&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B121-ijms-21-01193" ref-type="bibr">121</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">lncRNA ANCR</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">NCI-H23, NCI-H522</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">ANCR&#x2192;TGF-&#x3B2;1&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B122-ijms-21-01193" ref-type="bibr">122</xref>]</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">lncRNA NKILA</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A549, H226</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NKILA&#x2192;NF-&#x3BA;B&#x2193;&#x2192;Snail&#x2193;&#x2192;EMT&#x2193;&#x2192;invasion&#x2193;, migration&#x2193;</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-ijms-21-01193" ref-type="bibr">123</xref>]</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p><bold>Abbreviations:</bold> nc-RNA, non-coding RNA; miR, microRNA; EMT, epithelial-mesenchymal transition; TGF-&#x3B2;, transforming growth factor-&#x3B2;; SULF2, Sulfatase 2; ZEB1, Zinc finger E-box-binding homeobox 1; MTDH, metadherin; FOXM1, forkhead Box M1; FOXQ1, forkhead box Q1; Sp1, specificity protein 1; SOX4, sex-determining region Y-box 4; TGFBR1, TGF-&#x3B2; receptor 1; CCNE2, cyclin E2; AKT, protein kinase B; CSCs, cancer stem cells; lncRNA, long non-coding RNA; LINP1, lncRNA in nonhomologous end joining (NHEJ) pathway 1; NF-&#x3BA;B, nuclear factor-kappa B; NKILA, NF-&#x3BA;B Interacting LncRNA.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>